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CHARACTERIZATION OF A MURINE GAMMAHERPESVIRUS IN VITRO
LATENCY SYSTEM
Kudakwashe Mutyambizi, Yale University School of Medicine (Sponsored by Michael
Kashgarian, Department of Pathology, Yale University School of Medicine, and Stacey
Efstathiou, Department of Pathology, University of Cambridge)
The human gammaherpesviruses EBV and KSHV realize their oncogenic potential
during latent infection. The species specificity of the human gammaherpesviruses has
hindered the study oflatency in animal models. Murine gammaherpesvirus MHV-68
(MHV-68) may be used as a representative gammaherpesvirus for the study of latency.
The goal was to establish an in vitro model of MHV -68 latency using replication
defective MHV-68. ORF50 has been identified as the major viral trans-activator essential
for entry into the lytic replication cycle and necessary and sufficient for reactivation of
MHV-68 virus from latency. ORF50 null mutants (£;,50) can theoretically be used to
infect cells in vitro to facilitate an analysis of virus gene expression and episome
maintenance during latency. In this project £;,50 mutants containing the luciferase or
green fluorescence protein (GFP) under ORF50 promoter control were used to infect a
variety of cell types. 3T3 fibroblasts are a permissive cell line and were used for an initial
characterization of the ability of £;,50 MHV-68 to establish latency. B lymphocytes and
macrophages are the major reservoirs of persistence in vivo thus the ability of £;,50
mutants to establish latency in NSO B and RAW macrophage cell lines was explored.
Latency was readily established and maintained in 3T3 and RAW cells.The low
infectability ofNSO B- cells restricted the utility of this cell line in studies oflatency.
Examination of patterns oflytic and latent transcription in 3T3 and RAW cells coordinately infected with £;,50 MHV -68 revealed reactivation efficiencies of 40-60%.

Following long-term passage 6.50 exhibited stable transcription of two latency related
genes M2 and ORF73, with episomal maintenance of the viral genome, in the absence of
contaminating lytic infection. The results demonstrate the utility of 6.50 mutants for
studies of gammaherpesvirus latency in vitro.
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ABSTRACT
The gammaherpesviruses have in common the ability to establish latency in infected
hosts. The species specificity of the human gammaherpesviruses has hindered their study
in animal models. Murine gammaherpesvirus MHV-68 (MHV-68) efficiently infects the
laboratory mouse providing a representative gammaherpesvirus for the study of latency.
The goal was to establish an in vitro model ofMHV-68 latency using replication
defective MHV -68. ORF50 has been identified as the major viral trans-activator essential
for entry into the lytic replication cycle and necessary and sufficient for reactivation of
MHV-68 virus from latency. ORFSO null mutants

(~50)

can theoretically be used to

infect cells in vitro to facilitate an analysis of virus gene expression and episome
maintenance during latency. In this project

~50

mutants containing the luciferase or

green fluorescence protein (GFP) under ORF50 promoter control were used to infect a
variety of cell types. 3T3 fibroblasts are a permissive cell line and were used for an initial
characterization of the ability of ~SO MHV -68 to establish latency. In addition since B
lymphocytes and macrophages are the major reservoirs of persistence in vivo the ability
of ~SO mutants to establish latency in NSO B and RAW macrophage cell lines was
explored. Latency was readily established and maintained in 3T3 and RAW cells. In
contrast the low infectability ofNSO B- cells restricted the utility of this cell line in
studies oflatency. Examination of patterns oflytic and latent transcription in 3T3 and
RAW cells co-ordinately infected with ~50 MHV -68 revealed reactivation efficiencies of
40-60%. Following long-term passage ~SO exhibited stable transcription of two latency
related genes M2 and ORF73, with "pisomal maintenance of the viral genome, in the
absence of contaminating lytic infection. The results demonstrate the utility of ~SO
mutants for studies of gammaherpesvirus latency in vitro.

CHAPTER 1
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INTRODUCTION
The Herpesviridae

The herpesviridae are a family of viruses classified according to their characteristic virion
architecture. The virions consist of a single linear double stranded DNA molecule packaged
within an icosahedral capsid, ranging from 100-llOnm in diameter [Roizman et aI, 1991).
Surrounding the capsid is the poorly defined tegument layer, containing viral proteins, some of
which are necessary for virion formation. Closely attached to the outer tegument surface is a
membrane envelope resembling the cellular Golgi membrane, and containing immunogenic viral
glycoproteins [Fields et aI, 2001).

The herpesviruses have evolved from a common ancestor, but have diverged widely, with
branchings of their phylogenetic trees reflecting those of their mammalian hosts as they coevolved. On the basis of variation in genomic arrangements, gene content and biological
attributes, the herpesvirues have been subdivided into the Alpha-, Beta- and Gammaherpesvirus
subfamilies [McGeoch et aI, 2000).
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Alphaherpesvirinae

The alphaherpesviruses are grouped together based on their biological properties and sequence
similarities [International Committee on Taxonomy of Viruses, 2000] . As a general rule,
members of this family infect epithelial cells productively, have a short reproductive cycle with
efficient destruction of infected cells, and have the tendency to establish latent infection
primarily although not exclusively in sensory ganglia.

Betaherpesvirinae

In contrast to the alphaherpesviruses, members of this subfamily tend to be species specific and
cell type specific in culture. The reason for host restriction is not clearly understood, although
cell surface receptors have been implicated [Huemer et aI, 1995]. Often viruses can enter a
variety of cells but intracellular factors limit susceptibility. The betaherpesvirus growth cycle is
characteristically slow, the virus remaining cell associated, with cytomegalia frequently
occurring. Infection is rarely clinically apparent in immuno-competent individuals, with disease
manifesting in any organ in the immuno-suppressed.
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Gammaherpesvirinae

Members are included on the basis of overall co-linearity and genomic organisation. Infectivity
is restricted to the natural host, and latent in vivo infection occurs in lymphocytes with some
members also able to Iytically infect some types of epithelioid and fibroblastic cells [Roizman et
al. 1991). Acute infection frequently results in Iymphoproliferative disorders and both lymphoid

and non lymphoid malignancies are associated with many members of this subfamily
[Ackermann 2006).

The gammaherpesvirinae are further subdivided into the genus lymphocryptovilUs or
rhadinovilUs. The lymphocryptovilUses have only been found in primates. Members contain
homologues of the EBNA genes of Epstein Barr VilUs (EBV). B lymphocytes are infected by
these viruses in culture, and are latently infected in vivo. Infection ofB lymphocytes in culture is
generally non productive, but can lead to immortalization.

Members of the rhadinovirus genus are able to productively infect fibroblasts of multiple species,
and have been isolated from a wide range of mammalian species.
Latent infection has been identified in T and B lymphocytes. Kaposi's Sarcoma
Related Herpes
,
Virus (KSHV) and MHV -68 are rhadinoviruses infecting B cells, while HVS infects T cells.
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Table I
The human herpesviruses are listed according to type, cell tropism and site oflatent infection.
The mode of transmission is known for all the human herpes viruses, with the exception of
HHV -7. Adapted from pathmicro.med.sc.edu/virollherpes.htmIReferences: [Kumar et ai, 2005] ;
[Sheridan et ai, 2007] ; [Sinclair et ai, 2006] ; [Cesarman et ai, 1996].

iauman
iaerpes Name
~ype

Subfamily

~arget cell
type

Site of
fLatency

Mode of
Transmission

1

Herpes simplex ~lphaherpesvirinae ~ucoepithelia ~eurons
- 1 (HSV- l)

2

Herpes simplex
-2 (HSV-2)

~lphaherpesvirinae ,"ucoepi thelia fNeurons

Close contact
usually sexual

3

Varicella
Zoster Virus
(VZV)

~lphaherpesvirinae ~ucoepithelia !Neurons

Contact or
respiratory
route

4

fE1? s tein Barr

gammaherpesvirinae epithelial
cells,
B
lymphocytes

r-rirus

(EBV)

iB

Close contact

Saliva

lymphocytes

5

Fytomegalovirus ~etaherpes virinae JEPithelia,
jMonocytes.
lContact, blood
Im°ncyctes, B Lymphocytes transfusions,
lymp:,.ocytes land possibl :, transplantation I
others
congenital

6

~uman Herpes

~etaherpes virinae

T lymphocytes
~ontact,
and others
lymphocytes, respiratory
route
!monocytes

~uman

~etaherpesvirinae

rr l ymphocytes

rr

~irus 6

7

Herpes
irus
7
r-r

and others

rrlymphocytes, f'nknown
monocytes

fK,aposi's
Sarcoma
8

~ssociated

gammaherpesvirinae Endothelial
cells, B
lymphocytes

~erpesVirus
(KSHV)

5

iExchange of body
lymphocyt es fluids

B

Genetic Organization of the Gammaherpesviruses
Complete genome sequences exist for 12 gammaherpesviruses [McGeoch et ai, 2005].
Gammaherpesviruses have historically presented a challenge in phylogenetic organization due to
the inconclusive position of MHV4 (MHV -68) which is associated with a high level of sequence
change, and difficulty in resolving branching order within the Rhadinovirus genus. The position
of MHV -68 seems to vary with the analytical method used, and the accelerated rate of change in
the genome may represent some differences in biology to the other gammas. At the same time,
the high number of substitutions in the MHV-68 genome imparts some similarity to both
lymphocryptoviruses and rhadinoviruses [McGeoch et ai, 2005].

The gammaherpesviruses have maintained the overall genomic layout of the herpesviruses,
containing the conserved order of 42 genes belonging to the ancestral core set of mammalian
herpesviruses, within a region of unique sequence flanked by terminal repeat elements. These
genes vary however, as a result of extensive nucleotide substitution and local base pair additions
and deletions. Furthermore, members of the subfamily share a core set of eight gamma specific
genes, concentrated at a few genomic loci, which confer their special characteristics, notably
lyinphotropism and malignant transformation [Nicholas et ai, 1998]. However, as a result of
variations in genome size and base composition, no two viruses have identical complements of
these conserved genes [McGeoch et aI, 2001]. The genomes of four representative
gammaherpesviruses are shown in Figure 1.
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Figure 1

Genetic Organization of gammaherpesvirus genomes

Schematic representation of the organization of the gammaherpesvirus genomes based on
sequence analysis. Adapted from [Nash et ai, 2001] ; Fowler, personal communication. KSHV
and MHV-68 are rhadinoviruses infecting B cells, while HVS is a rhadinovirus latently infecting
T cells. On the basis of its genetic organization, and its mechanisms of latency establishment and
maintenance, MHV -68 is more similar to KSHV than to EBV,a lymphocriptovirus. The genome
ofEBV is shown in reverse orientation (Left to Right) to facilitate comparison to the
rhadinovirus genomes. Conserved genes involved in DNA replication and virion architecture are
represented by open boxes. The genes specific to the gammaherpesviruses are labelled above and
below the respective genome. Latency associated proteins are shown as orange boxes.

Abbreviations: CCPH: complement control protein homolog; CKBP: chemokine binding protein;
CRP: complement regulatory protein; DHFR: dihydrofolate reductase; EBNA-1
:Epstein Barr
_.,Virus nuclear antigen 1; LAMP: latency associated membrane protein; LMP: latent membrane
protein; STP :saimiri transforming protein; TK: thymidine kinase; TS: thymidylate synthase;
vFLIP: viral FLICE inhibitor protein; vGPCR: viral G-protein coupled receptor; vILl7:viral IL17; vIL6: viral IL-6; vILlO: viral IL-IO;vIRF: viral IFN regulatory protein; vMIP: viral
macrophage inflammatory factor; vOx2: viral Ox2
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EBV genetic organization

EBV is the only human Iymphocryptovirus. The genes responsible for host cell transfonnation
and maintaining the viral genome in dividing cells have been well studied in EBV and its primate
virus relatives [McGeoch et ai, 2001]. The left tenninal region of the EBV-l genome houses the
lymphocryptovirus specific LMP-l gene. The right tenninal region houses the latent membrane
protein LMP-2, LP and EBNA -2 genes. The EBNA-3 group of distantly related genes is placed
tandemly at an internal locus of the genome, as is the EBNA-l gene. A giant transcript which
extends across most of the genome produced in several versions undergoes differential and
complex splicing to express the EBNA and LP genes in latently infected and transfonned cells
[Zhang et ai, 1994]. This replication system is unique to the lymphocryptoviruses.

EBV pathogenesis

EBV ·is the causative agent of infectious mononucleosis, and is implicated in the pathogenesis of
Burkitt's lymphoma, some instances of Hodgkin's disease, immuno-blastic lymphoma and Blymphoproliferative disorder in immuno-suppressed individuals. Epithelial malignancies caused
by EBV include nasopharyngeal carcinoma and gastric lymphoma [Purtilo et ai, 1992] ; [Straus

et ai, 1993]; [Farrell 2002]. Rarely, T cells are infected, as is the case in EBV derived T-cell
lymphomas.
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Several viral genes collaborate to immortalize B cells. Viral LMP-l up-regulates bcl-2,
preventing apoptosis of B cells. LMP-l also activates growth promoting pathways, usually
stimulated by T cell delived signals [Hu et ai, 1993] ; [Kumar et ai, 2005]. In vitro, expression of
LMP-l renders rodent cell lines immortal, and occaisionally, tumorigenic [Moorthy et ai, 1993].
EBNA-2 activates LMP-l transcription, and trans-activates host genes such as cyclin D and the
src tyrosine kinase proto-oncogenes.

EBV is tropic towards epithelial cells ofthe oropharynx, and B lymphocytes. Viral uptake into B
cells is facilitated by CD21 present on B cells, with circularization of the viral genome to form
an episome. EBV enters latency upon infection ofB cells, due to a failure ofBZLF 1 to activate.
Reactivation requires activation of BZLF I which occurs on B cell differentiation to a plasma
cell.

KSHV genetic organization

KSHV was discovered in 1994 [Chang et ai, 1994]. Its molecular evolutionary biology has been
challenging to study, due to the diversity of the leftmost gene in its genome, Kl from HHV-8
isolated from different individuals. The Kl sequence encodes a type I glycoprotein which has the

-.

ability to transform cells with the diversity proposed to be either an immune evasion mechanism,
or a necessity for interaction with a host component that is quite variable in human populations
[Lee et ai, 1998] ; [McGeoch et ai, 2000] and consistent with human genetic diversification and
global spread.
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KSHV pathogenesis

KSHV is implicated in the etiology of the angiogenic tumor Kaposi's Sarcoma (KS), the HIV
associated Iymphoproliferative diseases Multicentric Castleman's Disease and Primary Effusion
Lymphoma [Soulier et ai, 1995] ; [Cesarman et ai, 1996].

Horizontal transmission by saliva is thought to be the most common route of transmission. KS is
described as a neoplasm of primitive mesenchymal or endothelial cells whose course greatly
depends on the immune state of the afflicted individual. Both HIV products and HHV-8' are
thought to playa role in pathogenesis, with locally produced cytokines acting in a paracrine or
autocrine way to stimulate unchecked growth of tumor cells [Kumar et ai, 2005].

Endothelial cells are believed to be the precursors of spindle cells, are the site of latent infection
in vivo, and are permissive to KSHV infection in vitro. A subset of infected cells manages the
larger microenvironment in KSHV infection. This conclusion is drawn from initial experiments
in vitro, where less than 10% of cells were infected after serial passage, yet, these KSHV

cu1tures had extended life spans, acquired telomerase activity and made colonies on agar suggesting that some transformation event had occurred [Wang et ai, 2005].
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Five KSHV proteins are produced during latency in infected lymphoma cells. These include
LANA-I, v-cyclin-D, FLICE inhibitory protein (v-FLIP), V-IL-6 and LANA-2.

A single

tricistronic mRNA is alternatively spliced into LANA-I, v-cyclin and v-LFLIP gene products,
the expression of which comes from an internal ribosome entry site (IRES) [Bieleski et ai, 2001].

LANA-l has transcriptional effects on both cellular and viral genes. It is required for episomal
maintenance, can transform cells, inactivates Rb and p53 thus immortalizing cells, and causes
lymphoid tumors in transgenic mice [Ballestas et ai, 1999] ; [Friborg et ai, 1999]; [Fakhari et ai,
2006]; [Radkov et aI, 2000]. LANA represses the RTA promoter, thus inhibiting the lytic cycle
and maintaining latency.

V-cyclin D acts as a cell cycle regulator, and in the absence of p53, destabilizes the cellular
genome, allowing for the expansion of tumorigenic clones [Verschuren et ai, 2004]. v-Bcl2 and
v-FLIP activate anti-apoptotic pathways and v-IL-6 is a viral cytokine stimulating clonal
expansion [Cesarman et ai, 1996] ; [Moore et ai, 1996]. Thus, the human gamma herpes viruses
EBVand KSHV are able to drive the proliferation of latently infected cells, causing lymphoid
and epithelial tumors, which occur with increased frequency following immuno-suppression.
Therefore, control of gamma herpes virus infections represents a major clinical goal.
"

Unfortunately, the species specificity of the human gamma herpes viruses EBV and KSHV has
hindered study of these human herpesviruses in animal models, and study of simian homologues
in primates has proved costly. The genetic and immunologic profile of the laboratory mouse,
however, has been well characterized.

12

MHV68 efficiently infects the laboratory mouse and presents a representative gamma herpes
virus whose pathogenesis can readily be studied in this small animal model [Adler et ai, 2001] ;
[Nash et ai, 2001] .

MHV -68 Genetic Organization

The complete genome ofMHV-68 clone g2.4 is available, with 81 genes identified [Virgin et ai,
1997] ; [Nash et ai, 2001] . In addition to the cellular homologues and genes conserved in the
genus, a unique set of genes Ml to M4 are present in the genome, and a set of eight virally
encoded tRNAs expressed during latency, of undetermined function [Bowden et ai, 1997] ;
[Macrae et ai, 2003] ; [Simas et ai, 1998]. tRNAs contain the polIII promoter driving expression
of miRNAs, which regulate gene expression post transcriptionally [Pfeffer et ai, 2005]. The
MHV-68 genome encodes the well conserved genetic sequence ofORF50, which is homologous
to ORF50 in KSHV, HVS, RRV and BRLF1 in EBV [Damania et ai, 2004].

ORF50 has been identified as the major immediate early gene encoding Rta, the viral
transcriptional activator. Rta has been shown to be necessary and sufficient to induce the full
lytic cycle of gene expression, similar to the role ofRta in KSHV and EBV. This protein plays a
central role in viral reactivation from latency [Liu et ai, 2000] ; [Wu et ai, 2001]. ORF50 is the
sole trans-activator and thus the regulator of the switch between lytic and latent cycles in all
these viruses except EBV which also encodes BZLF1, with its gene product Zta implicated in
this process.
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MHV-68 pathogenesis

MHV-68 was originally isolated from bank voles in Slovakia [Blaskovic et ai, 1980]. Chandra et
al showed that MHV-68 was able to latently infect a range of B cell lines, including NSO mouse
myeloma cells, with reactivation and lytic gene expression occurring in approximately 5% of
cells [Sunil-Chandra et ai, 1992].

The natural route of transmission ofMHV-68 is unknown. However, following intranasal
infection oflaboratory mice, viral replication occurs in lung epithelial cells. Long-term latency is
established primarily in B lymphocytes, and macrophages are the major reservoirs in peritoneal
cells, although virus also persists in lung epithelial cells and dendritic cells [Weck et ai, 1999] ;
[Simas et ai, 2004].

CD4+ T cells mediate splenic B and T cell expansion, resulting in splenomegaly within two
weeks. By the third week post infection, an infectious mononucleosis like syndrome occurs, and
with chronic infection, approximately 10% of mice develop B celllymphoproliferative disease
[Nash et ai, 2001]. In tissue culture, murine B cells exhibit CPE within three to four days post
infection, and die within two weeks as no transformation occurs [Dutia et ai, 1999]. Addition of
cytokines and other growth factors to media may prolong the life of cultures to two months, but
no immortalized cell lines have been established. Infected B cells in culture do however show
increased survival over mock infected cells, with MHC I expression increased, and virus
encoded tRNAs identified in infected B cells, but no lytic transcripts evidenced.
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BALB/c beta2 micro globulin deficient mice (BALB beta2m-/-) have proved useful for studying
MHV-68 pathogenesis. MHV-68 infection results in B cell lymphoma (B220+/CD3-) and
atypical lymphoid hyperplasia resembling lesions in EBV associated post-transplant
lymphoproliferative disease [Tarakanova et at, 2005].

While our knowledge of gannna herpes virus pathology has vastly increased, there still remain
many outstanding questions. The early events of gammaherpesvirus infection remain unclear, as
does the role of viral genes in initial infection, the mechanisms involved in the transition to
latency, the sites oflatent infection, the role of the immune response in limiting virus infection
and contribution to the immuno-pathology associated with the gannnaherpesviruses.

The ability of the herpes viruses to establish and reactivate from latency is central to the survival
strategy of these viruses. The aim of this reseal"ch is thus to establish an in vitro model of MHV68 latency which can be used to characterize the latency gene products encoded by this virus.

The MHV68 genome has been fully sequenced and cloned as an infectious Bacterial Artificial
Chromosome (BAC) [Adler et at, 2000]. Using targeted mutagenesis of the MHV-68 BAC,
MHV -68 mutants can be constructed and reconstituted in vitro by transfection into eukaryotic
cells, for analysis. Given the central role of ORF50 as viral trans-activator between latent and
lytic cycles, the generation of ORF50 mutants provides an ideal system for studying the
mechanisms involved in latency establishment and reactivation from latency [Virgin et at, 1997].
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Models for MHV-68 Latency

Other model systems are in use for the study oflatency however they each have significant
limitations. The Sllcellline is derived from a B -cell lymphoma from BALB/c immunodeficient mice latently infected with MHV-68 which subsequently developed
lymphoproliferative disease [Usherwood et at, 1996]. The S 11 cell line has provided an
amenable system for the study of latency as this is a clonal population in which every cell
co'ntains tbe MHV -68 genome,

For example, the latency associated gene product M2 which has anti-apoptotic properties was
discovered by analyses on this cell line [Macrae et at, 2003]. Furthermore, virus can be
reactivated from latency by supplementation of the ORF50 gene product in trans [Wu et at,
2000]. There are however, limits to the utility of this system in the study oflatency. While
reactivation frequency is low, S 11 cultures can undergo spontaneous reactivation, thus producing
lytic gene products, with cultures becoming increasingly lytic with each passage [Husain et at,
1999]. Furthermore, given the derivation oftbis cell line from lymphoma cells latently infected
in'vivo, the possibility exists that more than one viral genome may be integrated in tbese cells
[U sherwood et at, 1996].

The NSO cell line, also ofBALB/c origin is a myeloma derived line which is attractive for the
study oflatency given that B lymphocytes are the natural site oflatent infection in vivo [SunilChandra et at, 1992]. NSO cells infected with MHV-68 yield predominantly circular genomes,
indicating latent infection.
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Some infectious virus remains detectable in latently infected cultures however, with a small
proportion oflinear genomes present indicating lytic infection. The linear genomes are
successfully abolished with application of acyclovir [Sunil-Chandra et ai, 1992]. The
requirement for acyclovir treatment to maintain latency makes this model system less than
desirable for in vitro studies oflatency.

Both of these model latency systems are thus based on producer cell lines in which there is
always a background level of lytic replication taking place, limiting their utility in the
characterization of the latent transcriptional profile, and the identification of novel latent
transcripts.

Rationale/or the ORF50 latency system

In the rhadinoviruses, a single key transcriptional activator, Rta, encoded by ORF50, initiates the
lytic cascade [Hardwick et ai, 1988]. The transcription of Rta in the presence of cyclohexamide,
a protein synthesis inhibitor, identified it as an immediate early gene product [Liu et aI, 2000].

Kinetic studies performed in MHV-68 infected BHK-21 revealed that the ORF50 transcript is
the major transcriptional product produced by 2 h.p.i. Reactivation studies in latently infected
S 11 cells indicate that transfected Rta cloned into an expression plasmid can disrupt latency,
resulting in initiation and propagation of the lytic cycle [Wu et ai, 2000] .
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The trans-activating function ofRta has been localized to the C terminus, while the highly.
conserved N-terminus mediates DNA binding and dimerization [Lukac et aI, 1999]. Rta mutants
with deletions in the C-terminus trans-activating domains lose the ability to initiate lytic gene
expression. Furthermore, cell lines stably expressing these null mutants are resistant to lytic
infection with WT MHV-68 as the competing non functional Rta product inhibits functional Rta
auto-activation [Wu et aI, 2001].

The ORF50 gene encodes a spliced and unspliced product, with the transcription initiation site
for both products located downstream of ORF49. The ORFs 49 and 50 are encoded on opposite
strands and face each other, with ORF49 interposed between the two exons ofORF50. During
splicing to produce the major Rta transcript the region antisense to ORF49 is removed with
extension of the ORF50 gene, a conserved feature of gammaherpesvirus ORF50 [Whitehouse et
aI, 1997] ; [Liu et aI, 2000] .

The function of the un-spliced transcript in MHV-68 remains to be elucidated, although multiple
bicistronic alternatively spliced ORF50 transcripts have been identified in KSHV and RRV.
Prior studies in HVS indicate that the spliced transcript encodes the lytic gene trans-activating
abilities ofRta [Whitehouse et aI, 1998; De Wire et aI, 2002].

A Rta null mutant has been previously described, in which a stop codon was introduced into the
spliced ORF50 transcript coding region accompanied by a 2bp deletion resulting in a frame shift
[Pavlova et aI, 2003]. Contaminating WT virus was present in 1 in 3 xlO 4 to 1 in 10 5p fulml.
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In vitro studies revealed that the ORFSOstop mutant was replication defective, unable to replicate
viral ORFSO DNA as assessed by RT-PCR, however WT replication could be initiated when
ORFSO was supplied in trans in a complementing cell line. Immunoblot assays indicated that the
ORFSOstop mutant failed to produce viral proteins by 24hpi, compared to WT virus, which
produced several lytic proteins.

Murine in vivo studies using this MHV-68 t..SOstop mutant revealed that the replication defective
mutant virus persisted in B cells at the site ofinfection (lung) but failed to establish latency in the
spleen indicating that virus replication is necessary for the overall establishment of splenic
latency [Moser et ai, 200S].

In addition to ORFSO's transcriptional regulation of the viral genome, Rta exerts transcriptional
effects on the cellular genome as well. An MHV68 mutant over-expressing ORFSO has been
shown to dysregulate transcription of cellular genes involved in cell adhesion (VCAM-l), cell
growth (FGFIO) and inflamrnation(Tnfip6), and consistent with WT MHV-68, up-regulate
nuclear hormone receptor Nur77 and immune inhibitory hilla, for example. These cumulative
effects are potentially crucial for lytic replication [Hair et ai, 2007].

Studies in S 11 cells showed that time of expression is closely linked to function in the
transcription program ofMHV-68 [Usherwood et ai, 1996]. The activation of the ORFSO
promoter results in the trans-activation of other IE viral transcriptional regulators, such as ORFS7,
which like ORFSO peaks within 8 hours post infection, and are identified by transcription of their
mRNAs in the presence of protein synthesis inhibitors [Martinez-Guzman et ai, 2003].
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Furthermore, Rta also regulates its own promoter through the Oct-l transcription factor, and
assists in Sp-l mediated and general transcription [Zhang et ai, 1998]. This auto-activation
results in the irreversible progression of the lytic cascade. IE gene products activate delayed
early genes (DE) encoding proteins effecting viral DNA replication, such as ORF9 encoding
viral DNA polymerase, expressed 8 to 12 hours post infection.

Early (E) gene products include among others M7 glycoprotein 150 and ORF 49, peaking
between 12 and 24 hours post infection, with the eventual activation oflate (L) genes encoding
viral structural proteins whose production peaks at 12 to 24hpi [Martinez-Guzman et ai, 2003] .
Latency associated gene products such as M2 also peak late in infection, after 32 hours. Rta can
negatively regulate transcription of the Latency Associated Nuclear Antigen encoded by ORF73
[Hair et ai, 2007]. Interestingly, ORF73 encoding the Latency Associated Nuclear Antigen, is an
immediate early gene, peaking within 8 hours post infection, yet it is the key regulator ofthe
latent state, analogous to ORF50 in lytic infection [Ballestas et ai, 1999].

The time course of its expression indicates that while lytic infection is the default pathway upon
plimary infection in vitro, the viral survival strategy of latency is initiated early on in the process
of infection. LANA acts by repressing the transcription ofORF50 [Lan et ai, 2004]. Reactivation

-,

occurs under chemical induction by agents initiating activation of cellular pathways resulting in
de-repression of the ORF50 promoter. For example treatment with trichostatin A (TSA) results
in inhibition of histone deacetylase, with subsequent de-repression [DeWire et ai, 2005] .
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Ectopic expression of ORF50 in latently infected cultures, results in reactivation, and the
conservation of its function is evidenced by the ability ofMHV-68 and RRV ORF50 to
reactivate KSHV from latency [Damania et ai, 2004]. In summary, ORF50 is necessary and
sufficient for reactivation from latency, thus ORF50 null mutants present an ideal system in
which latency can be studied.

These mutants can be generated using the BAC plasmid cloning and mutagenesis protocol, with
subsequent reconstitution of mutant virus in cell culture [Adler et ai, 2000] ; [Adler et ai, 2001].
These IE deficient mutants can then be utilised to co-ordinately latently infect large numbers of
cells in culture.

Prior to my arrival, the Efstathiou lab had created an immediate early gene mutant carrying the
reporter gene luciferase instead of ORF50, under the ORF50 promoter. Given that the ORF50
promoter is suppressed during latent infection, and activated during lytic infection, it appeared
that the presence of this reporter gene could be used as an indication oflytic infection. It had so
far been demonstrated that latent -infection could be established in BHK-21 cells, and
furthermore, the virus could be reactivated from latency.
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AIM

My project involves the next step, which is determining whether the !':.50 latency system
represents an inducible and reliable latency system, devoid of the lytic contamination that has
confounded previous latency systems. This involves establishing latency in the model 3T3 cell
line, and testing this process in a macrophage and B cell line, where latency occurs in vivo.
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CONSTRUCTION AND CHARACTERIZATION OF THE 1\50 MUTANT

Materials and Methods

Reagents

General reagents were provided by Sigma Chemical Company and Aventis. Plastics used in
tissue culture were supplied by Falcon and TPP Ltd. PBS was prepared by the technical staff at
the Department of Pathology. All other reagents used and their suppliers are listed in Appendix 1.

Cell Lines and Tissue Culture

1'-.50 mutants are replication defective, thus a complementing cell line supplying ORF50, the
3T3/0RF50-fibroblast line, Clone 11, was developed to grow viral stocks (Figure 2).
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NIH 3T3 , Clone II, NSO and RAW macrophage cells were cultured in DMEM supplemented
with 10% FCS, 4 mM L-glutamine, 100U penicillin G mrl, 100mg streptomycinmr l and 1%
non essential amino acids. Clone II cells were supplemented with 200uglml hygromycin,
200uglml G418, 5uglml puromycin to maintain repression of ORF50 production. Baby Hamster
Kidney-21 cells (BHK-21) were grown in GMEM containing 10% FCS, 10% tryptose phosphate
broth, 2m.M L-glutamine, 100 U penicillin mr], and 100ug streptomycin mrl.

Cells were grown by incubation in 50ml flasks, at 37°C in a 5% C02 humidified environment.
Cells were harvested on reaching confluence by removing media, rinsing with PBS,
trypsinization with incubation to release single cells from the monolayer matrix, and pelleting by
centrifugation at 1500 rpm in a IEC 6000B rotor. Cells were then re-suspended in fresh media,
plated in a new flask, and in this way maintained over several generations of cell division.
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Figure 2
Schematic Diagram showing the design of the inducible Clone II cell line supplying Rta in trans
to !'.50 mutants (Adapted from the Clontech Tet On System Advanced Manual).

The Clontech tetracycline inducible system was adapted to generate an ORF50 complementing
mouse embryonic fibroblast cell line, Clone II (Coleman, Bennett, personal communication).
The tetracycline responsive element (TRE) promoter encoding a HCMV promoter and several
tetO sequences hybrided onto the tetracycline trans-activator tTA in the presence of a silencer
element (tTS) were fused to generate a 3T3 fibroblast cell line stably expressing TRE-rtTA and
CMV-tTS. Transduced cells were selected using the antibiotic resistance markers puromycin and
hygromycin respectively. The genomic fragment containing ORF50 (66754 to 69377) with an
ATG at 66760 bp and an ATG at 67661 bp on splicing was amplified by PCR, including EcoRI
and ClaI restriction sites in the 5' and 3' primers. The ORF50 PCR product was cloned into the
5' end on Sail site on pREVTRE and the pREVTREORF50 retroviral expression plasmid was
then transfected into NIH-3T3 cells already containing the TRE-rTA and CMV-tTS cassettes.
ORF50 was thus inducibly produced in trans in the presence of doxycycline, and suppressed in
its absence.
Key
3T3-Clone 11: inducible 3T3 fibroblast cell line supplying ORF50
pCMV: cytomegalovirus promoter
DOX: doxycycline
MHV -68/TRE50: cloned MHV68 ORF50 gene under TRE promoter control
rtTA: reverse tetracycline trans activator
pTRE: tetracycline responsive element promoter
tTs: tetracycline silencing element
50: ORF50 gene product
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Table 2
Description of cell type,infectivity and source for cell lines used.

Cell Line
BHK-21

Cell type
Fibroblast

NIH 3T3-

Fibroblast

Clone 11 (NIH

Fibroblast

3T3/0RF50-)

RAW 264.7

Macrophage

NSO

BALB/c
myeloma
derived
lymphoblast

Description
Permissive
mouse
embryonic
kidney cells
Permissive
mouse
embryonic
fibroblast line
As above,
supplementing
ORF50 in trans
on induction with
doxycycline

Non permissive,
enhanced
infectivity with
antigp150
antibody, latent
site in vivo
Non permissive,
primary site of
latency in vivo
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Source
(American
Type Culture
Collection,
CCL-IO
American
Type Culture
Collection,
CRL-I658)
American
Type Culture
Collection,
CRL-1658)
Coleman, H.M
p,ersonal
communication
Rosa, personal
communication

American
Type Culture
Collection
CRL-11177

Viruses

Several t.50 recombinant viruses were generated by the laboratory ( Coleman, Freitas, personal
communication), using the BAC mutagenesis protocol [Messerle et ai, 1997] ; [Borst et ai, 1999].
The ORF50 ATG translation initiation codon is located at 67907 bp, and the gene comprises of2
exons interposed by ORF49. The genomic fragment with genomic co-ordinates 66642-69462 bp
contain the entire ORF 49 and ORF 50 [Liu et ai, 2000]. Splicing removes the intronic ORF49,
with extension of the ORF to encode an additional 94 amino acids likely encoding an ATG site
as occurs in KSHV [Sun et ai, 1998]. Putatively, the ORF50 promoter is located between 6644266552 bp, with a TATA box from 66439-66444bp. Briefly, the genomic fragment from 6384470433bp was cloned into a pUC19 shuttle vector in the HincII site, and an oligo adaptor
containing ClaI (69177) restriction site added into the BsmI site (67792). ClaI digestion enabled
excision of a 1385bp fragment (67792-69177) from exon 2 leaving a 5' 131bp overhang (6766167792) with an additional 41bp contributed by exon 1 on splicing. A 196 bp (69177-69373)
overhang remained at the 3' end of exon 2. Luciferase derived from p21uc then replaced the
deleted ORF50 gene sequences with a 978bp (658-1636bp) and a 1922(l658-3580bp) reporter
gene fragment, with the sequences cloned into the p.UC19/HincIIB plasmid digested with ClaI.
An alternative reporter system was constructed by attaching the enhanced GFP coding sequence
to ORF39 (56950-55799) encoding the late glycoprotein gM at the C terminus, onto this t.50
knockout background (Smith, personal communication; [May et ai, 2005] ) . The mutated
MHV68 gene fragment is shown in Figure 3, and a schematic representation of the mutant
viruses is shown in figure 4.
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Figure 3: Nucleotide Sequence of the MHV-68 ORF50 gene adapted from MHV-68 nucleotide sequence, GenBank
Accession Number AFI05037. The sequence is shown 5' to 3 'from 67660 to 69373 base pairs, which spans the
ORF50 Exon 2. The ATG site, at 66760bp, precedes ORF49, and is capitalized. The deletion from 67792-69177bp
of Exon 2 is highlighted in blue. The 5' and 3' overhangs of Ex on 2 remaining after deletion are highlighted in red.
66721 aaaaataeaa eteetgeaet aegagggaat ttetgeageg ATGgeetetg aeteggatte
66781 eeetteagee gataaggtag gtaaaeattt tatataaatt tgtaaaeeae geagaeagat
66841 eagtatttea teaaaaaeta aagtgttgtt aetagtetga agtetgtgga geagatggtt
66901 taagttagae aattttgeee aeaeaaeaga tgtgetatag eagageaggt ttgtgteaga
66961 tteeaeaate gettetaaet ettttaeatg atttttaaaa agggeattaa atgeeaeaag
67021 getgteeage agaaaetgae tttggaeaea aaeaetgaae agtttaaaga egettaeeea
67081 ataeaeaagg aeattgagte eagtagataa ateaaagtet geagetgttt etaaetetag
67141 tgaataettt aagaatgttt taaagttgta eatataagaa aagtgtttat tgteeaaeat
67201 agaagatatt ttteteaagg etteetegte taeagaggte aggaaaeatg eaeaeeatte
67261 atgtaeagge tgatetttgt eatatgggat agaeaaaate tetggaettt gaeageeeag
67321 taaattgaea gtgeetatgg eeaagtettg taaeaagttt gaateatttg eeteaaggga
67381 tagetteatg tagtegagta tgegetgaaa tttggaggta gtggaeaaee teteeaatag
67441 tgttaggtgt etgataatta gtteeeteaa gtggggeaae aaaaatgget etgtateeaa
67501 gttgtggege agtgtetgae aaattttaea eageaeetga agettaeaea aaeaggeaet
67561 taetetatta tgtteeetag tatetatgae aeaaaaggtg tggaeeaege ttteeagaga
67621 aggataataa aatteateee eeatgtttte tgttettata ggaetggeae ggategaage
67681 aggtetaett gageeagttg attggagtet etgetgaaae aaaagaggaa ttteageaae
67741 tggtagatet atttatatge tteetaeage aeeetgaaga tggtttgaat getetgeagt
67801 atgteaagaa tttggaaett getettegge gtetgeagte agaeagtete aaaeatggge
67861 etttgtetgg gttaatattt gaeetgaaet tetaeaatgt etgggtaatg tteagaaaee
67921 agaaggtgag gtttaatgee aaagteeata aeaggeatee atgtgggtae atateteaee
67981 aeetgateaa atatgeeatt gaaagagttg tetataeeae agaeaggetg tttetgaetg
68041 eeeeatgtte gggggtaeag etaeeteaae etetggeetg eagtetgtte gaaataetea
68101 aggatgttag aggaaaatge aeaaeggeet ggaggegett aggggeagge egeagaeatt
68161 taatgaeatt tgggegeaat gtgttggatg aatttaatte tgagaagaag teaeetggtg
68221 geatateeag agaagttgag geatttataa agatatgett teeaeaaatg gaettaaata
68281 aaattttaat teeaatttat eageaegeea teaaeateee aeeagaetgt gtaeeeaget
68341 gtaetattgg agatggaaae agaaaaegag eeeeeeaegg ttegetatae agtaaagaea
68401 tateeteaea aaagttetge ateeeagaee eeetgtttge tteteeeaea gaaeeagggt
68461 tgggggagtt geataggggt aatatggeae atttgetgea gaaeeeagaa gaaateatta
68521 aeetggaeee tetaeaeaat aeeaetgaae eetgtttgta teaaatgttt teagaggegg
68581 tgaeaaaeee etetaaaaaa agatggettt ettettteaa eatggtettt teaggaetgt
68641 eteegagage teggeeagag aeeaettatg aaeeattggg geeattttea eeeattagee
68701 etggeeette tteegeeaea gaagagttee agtttgaatt tageeettet eeteaaaeet
68761 eeeeagaaae aagegageag agetaeatae etaeteeeaa eteagetatg ggeggateet
68821 ttgagtaeae aggegeegtt eaaeeaeaae taatteeaga taateaeaee tgtteegeaa
68881 agagattaag ggagagegat gaggaggtaa attattette agaeggtagt eeaaaeaaga
68941 aaeeeaeage tegeaettet gggeaegaae aggettatgg ttttetggee gagttgetet
69001 etageeaeag ggataegeet gteeageata ttgtgeaate tggeteaaeg eeegeeeege
69061 eaattgttga geeteaggga eaagattttg ttggaaaaea ggatgagaea tgtteeaaeg
69121 tgtteeeaga aeaaattaet eaggaagegt gteeeggate atetgaggae gegtteateg
69181 atgatgetat aaaggaaata tttgeatege tggaetetat ggeaaaeeag gaeaetgetg
69241 acagtgacac atgttccata cttgaccccc aatcacccac tcccccaccc tccgttcccc
69301 eaataaetae aetetegttg tatgaeattt atgeeageat aettagteea etegaeeeaa
69361 aeageetgga gte

29

Virus Stocks

All viral stocks used were prepared by the author. Wild type (WT) viruses were grown on non
complementing BHK-21 cells, while b.50 viruses were grown on Clone 11 cells in the presence
of doxycycline at Img/m1. Cells were seeded at I X107, infected with virus at O.Olpfulml and
followed for plaque formation. Mock-infected (medium only) cells were included as negative
controls. By 4-5 days, 100% CPE was achieved. Cells were harvested by scraping into media,
collecting the supernatant into SOml flasks, and pelleting by high speed centrifugation for 7
minutes. Cell pellets and virus containing supernatant were separated and subjected to the
following treatment. Pelleted cells were sonicated for 3x20 seconds on ice, and the resulting
slurry collected as the cell associated (CA) viral stock. Supernatant was collected into Oakridge
tubes for ultracentrifugation using a Beckman Type JA 25.5 rotor at 18,000 rpm for 2 II hours.
Supematant was poured off and the resulting viral pellets re-suspended in I 0-12ml of 10%
DMEM. The resultant slurry was sonicated for 3x20 seconds on ice and aliquoted into l.5ml
eppendorftubes as the medium purified (MP) viral stock, and stored at -70°C. A list of wild type
and b.50 viruses used is provided in Table 3. Unless otherwise specified, WT virus used in all
assays was the PHA3.3 WT virus which is wild type MHV-68 contained within the BAC cassette.
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Table 3
The 6.50 and WT MHV -68 viruses used
Virus

Mutation

'Phenotype

True WT MHV-68

Strain g2.4

WT

PHA3.3

Contains BAC sequence

WT- revertant

REVERTANT from "SOluc

WT

"SOluc

ORF50 deletion replaced with
luciferase reporter gene

replication deficient, expressing
luciferase on Rta
complementation

"50IucgMGFP

ORF50 deletion with eGFP
attached to C-terminus of gM

Replication deficient virus,
expressing gM-EGFP fusion
protein on Rta
complementation

WT

' Both BAC positive and BAC excised viruses were available, with BAC cassette derived GFP expressed by BAC+
mutants on infection.
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Titration of Stocks

Virus titres were determined by monolayer assay. Aliquots of3001l1 of virus stock and 2.7 ml of
media were serially diluted and plated in duplicate over six well plates containing 3xl05 clone 11
cells + 1 mg/ml doxycycline for mutant virus assays or 2 xl0 5 BHK-21 cells for wild type
viruses, seeded the day before to confluence. Following a one hour incubation period, 3mls of
1% CMC was added to limit convective viral spread. Cultures were followed for CPE (3-4 days)
and harvested by removing CMC media, and fixing with 10% formaldehyde in PBS for 30
minutes. Plates were stained overnight with toluidine blue, rinsed, dried and individual plaques
counted at each dilution, in duplicate. The number of infectious virus particles in the original
virus suspension was then calculated.

Screening of Stocks for Wild Type Contamination

Stocks were screened for WT virus by seeding large T150 flasks with 10 7 cells overnight to 70%
confluence, and infecting with 10 5 , or 104 pfu of "'50 mutant virus. T75 flasks were infected
with 10 3 or 10 2 pfu of "'50 mutant virus. A Tl50 flask ofBHK-21 cells was infected with WT
virus at 10 2 pfu as a positive control. 10 ml of 3% FCS was added to infected cultures which
were then incubated at 37°C with shaking for 1 hour. 32ml and 20ml of 1% CMC was added to
Tl50 and T75 cultures respectively. Infected cultures were followed over the course of7 days
for green fluorescence and for CPE with plaque formation.
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At 7 d.p.i, 5ml of supernatant from infected cultures were placed onto fresh BHK-21 cells seeded
the day before to 70% confluence. These fresh cultures were incubated with shaking for lh at 37
°C, and 20ml of 3% FCS media added. Fresh cultures were followed over the course of 5 days
for CPE and green fluorescence, which would indicate infectivity of initial cultures, and
verifYing the presence of replication competen WT virus.

Growth Curves

Wild type revertant (WT -R) virus derived from L'l50luc (BAC+) was titrated in parallel with WT
virus and L'l50luc (BAC+) on BHK-21 cells. Six well plates were seeded with BHK-21 cells
overnight at 3 xl0 5 cells/ml, and infected at 5pfu/ml with either virus in 0.5ml media. An
additional 2.5ml media was added to the input plate, which was frozen immediately. The
remaining cultures were incubated at 3TC for an hour. The innoculum was removed from each
plate, washed with IX PBS, followed by 1ml of O.IM citric acid wash for 2 minutes at room
temperature to kill excess virus that had failed to penetrate the cells by that time. Citrate wash
was then removed, and cultures were rinsed x2 with 2ml of warm media. 3ml of media was then
added to cultures, and the t=O time point frozen immediately. The remaining cultures were
incubated at 37°C and frozen at the appropriate time points at -70°C. Celllysates were then
freeze thawed, and the amount ofvinis at each time point determined by plaque assay.
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Genome Copy Number

Medium purified virus stocks were titrated in parallel on the complementing Clone 11 cell line,
and the non complementing BHK-21 cell line as previously described.
200,..1 TE buffer (10mM Tris: 50mM EDTA p.H 8.0) was added to 3x50,..1 aliquots of virus
stock. 25 ,..1 of 10% SDS and 1 ,..1 20mgmr 1 proteinase K were added to samples, and incubated
at 37°C overnight. Samples were sonicated for 2xlmin to generate DNA pieces 5-6Kbp in size.
DNA was purified according to the Qiaquick PCR Purification kit protocol (Qiagen).

Serial dilutions were performed on triplicate DNA samples, which were subjected to real time
PCR on the Rotor Gene RG 3000 (Corbett Research) using TaqMan probes (Tib molbiol) and
primer set for ORF9 as detailed in the RT-PCR methods sec.tion (Chapter 3) amplified alongside
a standard curve.
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RESULTS

The goal ofthe current study is to establish a clean latency system in MHV-68 devoid ofiytic
background infection. An IE deficient mutant was generated by deletion of the MHV -68 ORF50
gene. The ORF50 gene was then replaced with the luciferase gene driven by the intact ORF50
promoter. The ORF50 deletion mutant with luciferase under the ORF50 promoter, denoted
~50luc,

was used in experimental work.

~501uc

provided the background for

~50IucgMGFP

in

which the late glycoprotein gM is fused to GFP resulting in GFP expression and subsequent
green fluorescence in lytic infection [May et al, 2005]. Furthermore, the MHV-68 genome is
contained within a BAC cassette, containing a human cytomegalovirus immediate early I
(HCMV IE) promoter driving GFP expression [Adler et al, 2000]. Thus WT and ~50mutants
express GFP from the BAC. BAC negative mutants in which the 8.8kbp BAC vector sequence
has been excised were also made. The characterization of these viruses is detailed.

The L1501uc mutant contains no secondary mutations

Cell mutagenesis procedures can introduce secondary mutations. Therefore, a selected mutant
may contain other mutations than the desired ORF50 deletion mutation as

r~combination

events

in eukaryotes are difficult to control [Messerle et al, 1997]. It is therefore only possible to verify
appropriate reconstitution of the designed mutation after growth and isolation of the constructed
VIruS.
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WT revertant virus generated by reverse mutation of il50Iuc(BAC+) showed identical growth
kinetics to WT virus in a single step growth curve, indicating that the ORF50 deletion had been
successfully engineered, and that no additional mutations had been acquired which could
contribute to the mutant virus phenotype. The il50tuc (BAC+) virus was unable to replicate on
non complementing BHK-21 cells (Figure 5).
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Figure 5
Growth Curve showing Kinetics ofWT, WT-revertant and Ll50luc (BAC+) replication over 48
hours. Non complementing BHK-2 1 cells were infected with either virus at 5pfu/cell, and
harvested at the appropriate time points. Titres at each time point were determined by plaque
assay.
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The LJ50luc (BAC+) and LJ50lucgMGFP (BAC-) null mutants are replication defective but .
recover growth characteristics on complementation

A growth curve comparing WT virus to 1l.50 viruses in the complementing clone 11 cell in the
presence of 1 mg/ml doxycycline showed that the 1l.50 mutants were able to recover replicative
fimction, with no deviation from the WT virus growth pattern in a single step growth curve
(Figure 6). In the absence of doxycycline, the t,50 mutants eventually underwent lytic
replication, although full complementation did not occur within the 48 hour time course. This
result indicates that the clone 11 cell line has leaky ORF50 expression, although induction with
doxycycline is needed for full complementation.
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Figure 6

Growth Curve showing Kinetics ofWT versus

~50Iuc(BAC+)

and

~50IucgMGFP

(BAC-) over

48 hours.

Complementing clone 11 cells supplying ORF50 in trans were infected with 5pfu/cell of

L150Iuc(BAC+) and L150IucgMGFP(BAC-) and harvested at the appropriate time points. Titres at
each time point were determined by plaque assay.
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lI50IucgMeGFP(BAC-)-dox

WTreversionfrequency is below I WTrevertant per 10 5 pfu 1150 in most 1150 stocks

WT reversion frequency was determined by plaque assay. Briefly, BHK-21 cells seeded at 1 x 10
7 cells/flask

and grown overnight, were infected with 10 5, 104 , 10 3 or 102 pfu of each virus stock.

Infected cultures were incubated with 1% CMC to prevent plaque confluence, and observed for
green fluorescence and plaque formation over 5 days. The number of plaques seen was divided
by the pfu of virus delivered and multiplied by 100 to give the % WT contamination listed in
Table 4. With the exception of b,50IucgMGFP(BAC-), all stocks were BAC +, and areas of
plaque formation showed clusters of green fluorescent cells, due to stimulation of the BAC
.derived HCMV-IE resulting in GFP expression during productive infection. No GFP negative
plaques were seen in the light phase, in either BAC + virus stocks or b,501ucgMGFP(BAC-). In
some b,50 BAC+ stocks, some single green cells were seen, without plaque formation or CPE.
The HCMV-IE promoter can also be stimulated resulting in GFP expression from latent genomes
possessing the BAC cassette. To determine whether these single green cells represented latent or
lytic infection, supernatant from b,50 infected cultures was placed on to fresh, uninfected BHK21 cells and followed for plaque formation. Only lytic virus is infectious, thus the ability to infect
fresh BHK-21 cells would confirm the presence of contaminating WT virus in the original b,50
infected culture.
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Frank CPE accompanied by plaque formation was seen only in the WT control, and in highly
contaminated stocks which were discarded, with 4 and 8 % WT contamination in media purified
(MP) and cell associated (CA) stocks respectively. In general, CA stocks showed higher
reversion frequency than MP stocks. Most stocks showed less than I in 105 pfu WT virus
contamination. The Li50lucgMGFP (BAC-) stock showed neither plaque formation nor green
fluorescence. <".50lucgMGFP (BAC-) provided the most rigorous screen of the <".50 mutant
stocks, as any GFP expression in this stock where GFP is fused to the late gM glycoprotein,
must identify virus late gene expression oflytic infection as a result ofWT contamination.

Only media purified stocks with <I in 105 WT contamination were used in subsequent
experiments, and assays were set up to deliver under 1 in 105 pfu/ml of <".50 virus stock to
minimize the possibility of delivering WT contaminating virus.
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Table 4

Reversion frequency in 6.50 virus stocks detennined by plaque assay.

Number of plaques seen by 5 d.p.i in BHK-2l cells infected with 6.50 stocks at 102 , 103 ' 104 or
105 pfu/flask and overlaid with 1% CMC are listed and used to determine the % WT
contamination. Appearance of 6.50 ' plaques ' compared to WT plaque are shown on the right
hand side.

TMTC*

Passaged
infectivity
YES

% WT
contamination
WT

Virus

Number of plaques

Wild type (bac +)
650luc(bac +)
Stock 1

Media Purified

40 in 10""3

YES

4%

650luc(bac +)
stock 1

Cell Associated

78 in

YES

8%

650luc(bac +)
Stock 2

Media Purified

1 in 10"5

NO

0.001%

650luc(bac +)
Stock 2

Cell Associated

5 in 10 AS

YES

0.005%

650gMGFP
(BAC +)

Media Purified

1 in 10 1\5

NO

0.001%

650gMGFP
(BAC +)

Cell AssoCiated

lin 10 1\5

NO

0.001%

650gMGFP
(BAC -)

Media Purified

0

NO

0%

650gMGFP
(BAC -)

Cell Associated

0

NO

0%

* TMTC denotes too

10 ~3

ITlany plaques to count .
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L150 viruses in complementing clone 11 cells have a high particle: pfu ratio comparable toWT
virus in non complementing BHK-21 cells

To further characterize the viruses, the genome copy number delivered to each cell during lytic
infection was determined. Viral DNA was extracted from equal volumes of media purified virus
stocks. To ensure accurate calculations, the same stock pot used for DNA extraction, within the
same thawing, was used to perform duplicate titrations of all viruses in parallel with one another,
on complementing clone 11 cells for both WT and L'..50 viruses, and on BHK-21 cells for WT
viruses for comparison.

The number of genome copies assessed by real time PCR was divided by the titre of virus in the
original volume of DNA extracted, to give the number of genomes delivered per cell, compared
to the number of viral plaque forming units. This gave the particle: pfu ratio, a measure of the
proportion of defective: infectious viral particles for each virus.

The L'..50IucgMGFP(BAC-) virus had the highest genome copy number at log 103.4, suggesting
a high ratio of defective to infectious virions. L'..50IucBAC+ also showed a high particle: pfu ratio
at log 102.1 compared to WT virus in the complementing clone 11 cell line. In the non
complementing BHK-21 cell line however, WT virus showed a comparable particle: pfu ratio to
that shown by the L'..50 viruses in Clone 11 cells (Figure 7).

43

Figure 7

Real time-PCR was conducted on triplicate aliquots of viral DNA using primers specific to the
ORF9 gene. WT and L'.50 viruses were titrated in parallel on the complementing Clone II cell
line, and WT virus compared on the non complementing BHK-21 cell line. The genome copy
number was determined by dividing the DNA copies obtained by RT-PCR by the viral
pfu/aliquot, determined by titration in BHK-21 and Clone II cells. The mean and standard error
is shown for two independent biological experiments.
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gMfused GFP localizes to the perinuclear membrane, while BAC derived GFP is pancellular

Confocal imaging provided high resolution images of infected cells, enabling localizaton of the
GFP in the different Teporter constructs. BAC derived GFP was found throughout the cell, in
both WI virus and in L150 virus containing the BAC cassettes, while gM fused GFP localizes to
a perinuclear location, a pattern consistent with gM localization to golgi membranes [Mach et ai,
2000] ; [May et ai, 2005].
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Figure 8

Clone 11 cells were seeded in the presence of 1mg/ml of doxycycline in individual wells, and
infected with 1 pfu/cell of either a) i1501uc (BAC+), b) i150IucgMGFP (BAC-) or c) WT (BAC+)
virus. Cells were imaged at 24 h.p.i in the green fluorescence phase. 3D Confocal Image stacks
of single cells were generated using the Leica Confocal Imaging Software.
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DISCUSSION

The 650 latency system provides a means by which latency can be established in vitro and key
questions addressed regarding latency. Fundamental to its design is the absence oflytic
competent virus from 650 mutant stocks, as this has confounded other latency systems [SunilChandra et ai, 1992) ; [Usherwood et ai, 1996). A previous 650 mutant has been described, with
1 pfu WT revertant present in 3 xlO 4 pfu to I xlO 5 pfu 650viral stock [Pavlova et ai, 2003), The
650 mutant used in that study was generated by incorporating a TAG stop codon at bp 67975,
and contained significant 5' and 3' sequences overlapping with the ORF50 sequence in their
ORF50 complementing cell line, contributing to WT reversion. In generating an ORF50 deletion
mutant, the Efstathiou laboratory was able to limit overlap to 172bp at the 5' end and 196 bp at
the 3' end without threatening the integrity of the adjacent ORF49 and M7 genes (Figure 9). As
the potential for recombination occurred with each passage through the ORF50 complementing
Clone II cell line, making stocks to submaster was a compromise which limited the opportunity
for wild type reversion while generating sufficient viral stocks for experimentation. In this
system which had the sensitivity to detect I WT revertant in 10 5 pfu of 650 virus, no WT
contamination was detected in the 650IucgMGFP(BAC-) stock, and I WT revertant in 10 5 pfu
of 65OJuc(BAC+) stock.
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Figure 9

Schematic Diagram Showing Overlapping between the ORF50 contributed by the Clone 11 cell
line, and the 5' and 3' fragments remaining after deletion ofORF50 in the Ll.50 mutant.
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The determination of WT reversion frequency in I'>.SO stocks relied on the expression of GFP
from viral genomes in the non complementing BHK-21 cell line. This cell line was used rather
than the non complementing 3T3 cell line as all titres for WT stocks had historically been
obtained on BHK-21 stocks and infection well characterized in this cell line. The I'>.SO mutation
confers a plaquing deficit on the MHV -68 virus as plaque formation represents focal areas of
productive infection in cell culture. Thus, screening BHK-21 cultures infected with 1'>.50 in the
anticipated experimental range of 102 to 105 pfu for plaque formation provided a good estimate of
WT reversion frequency. Given the observation that GFP expression from BAC sequences may
represent activation of the HCMV promoter in latent or lytic infection [Rosa et ai, 2007], areas
of GFP fluorescence were counted as plaques, even in the absence oflocal CPE in estimating
reversion frequency. Thus, a reversion frequency of 1 x 10 5 in the I'>.SOluc(BAC+) stock is likely
an overestimate, however all experiments using the I'>.SOluc(BAC+) stock were designed to
deliver under 105 pfu of virus, as the absence of WT virus from latent cultures was fundamental
to the design of this latency system.

Virus entry and lytic replication varies between cell lines [Bemfield et ai, 1999]. While WT
viruses are grown in BHK-21 cells, the kinetics of viral growth between 1'>.50 and WT virus
growth were compared in the 3T3 fibroblast ORF50 complementing cell line clone 11. The fact
that I'>.SO and WT virus attained the same growth peak in a high multiplicity growth·curve, not
only indicated that ORFSO supplied in trans fully complemented 1'>.50, but that even WT virus
had some additional ORFSO requirement for maximal lytic infection.
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WT virus showed very disparate particle: pfu ratios between complementing and non
complementing cell lines of approximately 10gIO 2.5 and log

10

1 respectively, suggesting that

some portion of cells infected by WT virus were entering latency on infection of BHK-2I cells,
but failed to enter latency in the presence of ectopic ORF50 supplied by the clone II cell line.

The high particle: pfu ratio exhibited by il50IucgMGFP(BAC-) virus suggests a higher
proportion of defective particles than other viral stocks. A role has been identified for defective
viral particles in modulating virulence [Cave et ai, 1985] ; [Browning et ai, 1991]' The
implication of this result is that infections with il50IucgMGFP(BAC-) may require up to 10 fold
higher virus titres to il50Iuc(BAC+). Ultimately, the reasons for differences in particle: pfu ratios
in different viruses is unclear, and may indicate secondary mutations that don't impact viral
growth kinetics, but affect infectivity. In order to discount this possibility, revertants of each
mutant would need to be generated, with particle to pfu ratios that reverted to WT.

By design, the il50 latency system relies on GFP expression to visually detect infection. Given
the ambiguity in determining whether green fluorescence indicates lytic or latent infection in
BAC positive stocks, it was useful to characterize GFP expression, and confirm the perinuclear
co-localization of gM and GFP, confirming the association of GFP

expressi~n

with lytic

infection in il50lucgMGFP(BAC-).

With a characterization of the il50 mutants and comparison to the WT MHV -68 phenotype, it
was possible to proceed with an exploration of latency.
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CHAPTER 2
ESTABLISHMENT OF LATENCY BY A50 MHV-68
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METHODS

Luciferase Assay

3I3 cells and clone 11 cells were seeded at 5 x104 cells/well in a six well plate, in the presence
of 1mg/ml for clone 11 cells. Cells were grown overnight to 70% confluence and were infected
with either t.50luc (BAC+) or WI virus (BAC+) at an MOl of 0.1 or 1, and harvested 24 h.p.i.
Cultures were washed 2x with PBS, and 400J.lI oflysis buffer added. After 10min, supernatant
was collected into tubes and centrifuged at 5,000 rpm for 1 min. 386J.ll ofluciferase assay buffer
and 100J.lI of cell supernatant or lysis buffer for the negative control added to assay tubes.
Luciferase assays were performed using the automated Luminometer (Berthold). Buffers used
are listed in Appendix L

Latency Experiments
3I3 cells or clone 11 cells were seeded as above, and infected with 0.1 , I or 5 m.o.i of t.50luc
(BAC+), t.50IucgMGFP (BAC-) or I m.oj WI (BAC+) virus in the various assays. Cells
were followed over the course of24 hours for GFP expression determined by observing green
fluorescence by fluorescence microscopy. In order to quantify the amount of GFP expression,
latently infected cultures were reactivated and compared to mock infected (media) samples for
green fluorescence by flow cytometric analysis on days 1,2 and 3, 7, 15, or 30 days post
infection. For 30 day experiments, cells were passaged every four days. For reactivation,
200J.lg/ml phosphonoacetic acid (PAA) was added to cu.1tures prior to super-infection with WI
(BAC-) virus at 5pfu/cell.
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20h post super-infection, cultures were analysed for GFP fluorescence, and the proportion of
GFP expressing cells in reactivated versus un-reactivated cultures compared by flow cytometry.

A similar protocol was utilized for infections in non-pe=issive RAW cells with the modification
that virus was pre-incubated lh prior to infection and titrated with the IgG gp150 specific
monoclonal antibody, TlA1, from BALB/c mice intra-nasally infected with MHV-68 (2 x10 4
pfu). Infections were carried out at 0.1, 1 and 5 m.oj of the

~50

viruses in the various assays,

and LPS at 100nglml added to cultures 3h prior to flow cytometry as LPS stimulates the HCMV
-IE promoter, revealing the cohort of cells infected with BAC+ virus. To titrate T1A1, aliquots

ofWT (BAC+) virus were incubated with serial dilutions ofT1A1 and used to infected 3T3 cells
at 1 pfu/cell. WT infected cultures were imaged at 24 h.pj in the presence of LPS. The dilution
ofT1A1 that gave the highest proportion of green fluorescent cells, was used from then on for
pre-incubation to potentiate virus for RAW macrophage infection.

Flow Cytometry

Cells were harvested at the appropriate time points by removing media, washing with 1ml PBS,
and trypsinization for 3T3 cells, and scraping into 1ml fresh media for RAW macrophages. Cells
were pelleted by centrifugation at 1500 rpm IEC 6000B rotor for 3112 minutes, and re-suspended
at 1 x 10 6 cells/ml in 1% BSA in 5ml round bottom tubes. Samples were assayed for green
fluorescence on a FACS Calibur using WNMDI software.
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RESULTS

Latency in 3T3 Fibroblasts

A reporter system to detect contaminating lytic virus

Initial experiments using the luciferase reporter system yielded very low counts for luciferase in
the WT and complemented case, with no clear pattern between latent and lytic samples. The
t.SOluc (BAC+) mutant was subsequently sequenced, and it was found that the luciferase gene
was cloned out of frame. Sequencing confirmed that the t.SO mutation was intact (Coleman,
personal communication). Initial growth curves indicated that no secondary mutations had been
introduced, and that supplying ORFSO in trans fully complemented the t.SO mutation (Figure S &
6). Luciferase expression could thus not be explored as a marker oflytic infection, however the
integrity of the t.SO mutation in the t.SOluc mutant was conserved, and this mutant was used for
further experimentation. An alternative reporter system based on OFP expression was thus
explored.

The MHV-68 genome is maintained within a BAC, enabling targeted mutagenesis. The BAC
cassette contains OFP under the strong HCMV-IE, which is activated by viral transcription
activators and cellular transcription factors, and is thus expressed during lytic infection. OFP
expression from the BAC cassette indicates that the viral genome is transcriptionally active, and
has previously been used as a convenient marker oflytic infection [Adler et ai, 2000] ; [Moser et
ai, 200S].
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In the complementing cell line, lytic infection in Ll.50 infected cultures appeared similar to WT
infected cultures with respect to green fluorescence and plaque formation, consistent with their
similar growth kinetics (Figure 6). In the non complementing 3T3 cell line, reactivated Ll.501uc
(BAC+) cultures looked very similar to WT infected cultures with green plaques seen, while unreactivated Ll.501uc (BAC+) cultures showed single green cells, but no plaque formation (Figure
10). This result indicated that green fluorescence provided a good visual screen oflatent versus
lytic infection in Ll.50 infected cultures. Green fluorescence in Clone 11 cells infected with
Ll.501uc (BAC+) without doxycycline was ambiguous as the sparse green fluorescence could
either reflect latent infection or a slower lytic infection due to leaky ORF50 expression, as seen
in Figure 6 (Figure 10).
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Figure 10

Complementing Clone 11 cells seeded in the absence (-dox) or presence (+ dox) of Imglml of
doxycycline, and non complementing 3T3 cells, were grown overnight. Cells were infected with
1 pfulcell of i150luc (BAC +) or WT (BAC+) virus. At 12 h.p.i, a subset of i1501uc (BAC+)
infected 3T3 cultures were reactivated by super-infection with 5 m.o.i ofWT (BAC-) virus, to
reveal latent i1501uc (BAC+). At 24 h.p.i, both un-reactivated and reactivated 3T3 cultures, and
clone 11 cultures, were viewed under fluorescence microscopy. Phase contrast images are
shown for negative control uninfected cultures while fluorescence images are shown for infected
cultures, imaged at lOx magnification.
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Recent studies have indicated that BAC derived GFP expression cannot reliably be used asa
marker ofiytic infection, and occurs in some latently infected cells [Rosa et ai, 2007]. To
eliminate ambiguity in determining whether ,1';.50 cultures were latently or Iytically infected, an
alternative GFP based construct was designed by gMGFP fusion on the ,1';.50 background, with
excision of the BAC vector sequences to generate ,l';.50IucgMGFP(BAC-) virus. This virus did
not exhibit green fluorescence in 3T3 cells by 24 h.p.i, and phase contrast imaging showed no
CPE or plaque fonnation. On reactivation of ,l';.50IucgMGFP(BAC-) infected cultures however,
green fluorescence was seen with associated CPE and plaque fonnation, indicating that gM
derived GFP is exclusively expressed during advanced lytic cycle, providing a superior marker
of lytic infection. A fraction of cells in Clone II cultures infected with ,l';.50IucgMGFP(BAC-)
without doxycycline were green indicating leaky ORF50 expression in this cell line, compared
to overwhelming lytic infection in the presence of doxycycline (Figure 11).
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Figure 11

Complementing Clone II cells seeded in the absence (-dox) or presence (+ dox) of Img/ml of
doxycycline, and non complementing 3T3 cells, were grown overnight. Cells were infected with
1 pfulcell of b.50IucgMGFP(BAC -) or WT (BAC+) virus. At 12 h.p.i, a subset of
b.50IucgMGFP(BAC-) infected 3T3 cultures were reactivated by super-infection with 5 m.o.i of
WT (BAC-) virus, to reveal latent b.50IucgMGFP(BAC-). At 24 h.p.i, both un-reactivated and
reactivated 3T3 cultures, and clone 11 cultures, were viewed under fluorescence microscopy.
Phase contrast and fluorescence images are shown for infected cultures, and phase contrast
images are shown for negative control uninfected cultures. Images are at lOx magnification.
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+dox

PAA at 200flgiml prevents viral spread

While the HCMV IE promoter is active in some latently infected cells, the full cohort of latently
infected cells do not express GFP during latency. Super-infection with WT (BAC-) virus at 5
pfu/cell provides ORF50 to quiescent Li.50 mutant genomes in latently infected cells, resulting in
coordinate reactivation oflatent cultures. In order to avoid overestimation of the proportion of
latently infected cells by this method, rescued Li.50Iuc(BAC+) viral spread from cell to cell must
be inhibited. PAA inhibits viral DNA polymerase [Honess et ai, 1977]. The efficacy ofP AA in
limiting viral spread was tested as described in figure 12 which follows the development of a
single plaque. Individual plaques were indistinguishable by 16h.p.i in the absence of P AA,
indicating that replication competent WT virus is able to spread from cell to cell. In the presence
of PAA however, a green cell noted at 4 hpi fails to develop into a plaque over 16h, as viral
replication and subsequent spread is inhibited.
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Figure 12

Non complementing 3T3 cells, were grown overnight in a six well plate. Ih prior to infection,
200flg/ml PAA was added to a subset of3T3 cell cultures. Both cultures without PAA, and
cultures containing 200flg/ml PAA were then infected with 0.1 pfu/cell of WT (BAC+) virus.
Infected cultures were viewed by fluorescence microscopy, at 4,8 and 16 h. p.i. Fluorescence
images are shown at 20x magnification
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Latency can be established and maintained/or at least 3 days in 3T3jibroblasts

These preliminary studies outlined a protocol for interpreting GFP reporter gene assays, for
establishing latent infection, and reactivating latent genomes. I thus proceeded with
characterizing latent infection with Ll.501uc (BAC+) in the 3T3 fibroblast cell line as described in
Figure 13.

The HCMV-IE promoter shuts off in the majority oflatently infected, un-reactivated cells over
the 3d time course, however a small proportion of cells remain green (13a). This may be due to
a cohort of cells in which the HCMV-IE promoter remains constitutively active, or changing
populations of cells in which the HCMV-IE promoter turns on and off. On super-infection, a
much greater number of cells are revealed to be latently infected (13b). The 12 h time point (l3bi)
appears too early to capture the full cohort oflatently infected cells, while cell death has begun to
occur by 48h (l3biii). Thus in all future experiments, reactivated cultures are imaged at 24 h post
reactivation (13bii).
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Figure 13
Non complementing 3T3 fibroblasts were infected with I pfulcell of t.50luc(BAC+) in the
presence of PAA. Cultures were followed for 3d, with super-infection with 5 pfulcell of WT
(BAC-) in a subset of latently infected cultures, at either 1,2 or 3d.p.i to reactivate cultures.
Cultures in which a) no reactivation occurred, and cultures b) reactivated at I, 2 or 3 d.p.i are
compared at each time point. Following reactivation, cultures were imaged bi) 12, bii) 20 or biii)
48 hours after reactivation, to determine the appropriate time to visually capture the full cohort of
green fluorescing cells. Fluorescence images are shown at 4x magnification.
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The same protocol was applied for latency experiments using MOlucgMGFP(BAC-) with the
caveat that no PAA was used (Figure 14). Given that gM is a late gene product the expectation
was that gM GFP expression would not be observed in cells infected in the presence ofPAA as
PAA blocks DNA replication and subsequent late gene expression. In this scenario, the
proportion of latently infected cells may be overestimated, compared to L\.50Iuc(BAC+), as viral
spread from cell to cell can occur in the absence of P AA.
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Figure 14

Non complementing 3T3 fibroblasts were infected with 1 pfu/cell of
.t.50lucgMGFP(BAC-) in the absence ofP AA. Cultures were followed for 3d, with superinfection with 5 pfu/cell ofWT (BAC-) in a subset oflatently infected cultures, at either 1,2 or
3d.pj to reactivate cultures. Cultures in which no reactivation occurred, and cultures reactivated
at 1,2 or 3 d.p.i are compared at each time point. Following reactivation, cultures were imaged
20 hours post reactivation. Fluorescence images are shown at 20x magnification
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days post infection

1150Iuc(BAC+) and 1150IucgMGFP(BAC-) have comparable reactivation efficiencies

Fluorescence microscopy gave a visual estimate of the proportion of reactivated, and thus
latently infected cells in culture. In order to quantify the efficiency of reactivation, 3T3 cell
cultures were analyzed on a FACS machine for green fluorescence. Reactivation efficiency
indicates the % of green fluorescence cells in a culture detected by flow cytometry, and implies
the proportion oflatently infected cells that were able to be reactivated. The protocol used in
analyzing samples is outlined in Figure IS. In order to assess the m.o.i of infection required to
achieve latency in at least a third of cells in cultures, infections were conducted at 0.1, I and 5
pfulcell of both viruses (Figure 16).
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Figure 15

A representative data set depicting the FACS analysis protocol.
3T3 fibroblasts were infected at Ipfu/cell of Ll.50Iuc(BAC+), and reactivated by superinfection
with WT(BAC-) at 5pfu/cell in the presence of P AA . The proportion of green fluorescent cells
was dete=ined by FACS for (Un) un-reactivated and (R) reactivated cultures.

The population of viable cells is selected according to size (forward scatter) and granularity (side
scatter), and gated as Region I (Rl). In plots b-d, i), ii) and iii) correspond to uninfected, latently
infected but un-reactivated(Un), and latently infected then reactivated (R.) respectively, which
are all gated through Rl. The intensity of green fluorescence of cells is plotted against cell
granularity (b). The regions containing auto-fluorescing versus green fluorescing cells are
defined as R2 and R3 respectively, according to positive or negative deviation from the +45 0
angle (c).The number of green cells within R3 was plotted against the range of fluorescence (d).
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Figure 16

3T3 fibroblasts were infected at 0.1,1, or 5 pfulcell of a) i1501uc gMGFP(BAC-) or b)
i150Iuc(BAC+), and reactivated by super-infection with WT(BAC-) at 5pfulcell in the presence
ofP AA for a) and in its absence (b). The proportion of green fluorescent cells was detennined by
FACS for (Un) un-reactivated and (R) reactivated cultures. A background level of fluorescence
in mock infected cells occurred in the green fluorescent range. This value was deducted from
FACS values for all infected cultures.
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5/R

For ~50lucgMOFP(BAC-), the background level of fluorescence observed in un-reactivated cells
appears stable at <2%, and is attributed to autofluorescence of cells in R3 (Figure 16a). There
appears to be a general increase in reactivated cells with MOlucgMOFP(BAC-) , which in the
absence of P AA is likely due to viral spread.

As previously seen, there was a decrease in the proportion of un-reactivated, latently infected
cells expressing OFP over the 3 day timecourse, following infection at both 1 and 5 pfu/cell
(Figure 16a) with ~50Iuc(BAC+). For both viruses at 5 pfu/cell, up to 65% oflatently infected
cells were reactivated. At 1 pfu/cell up to 50% of ~50Iuc(BAC+) infected cells and 30% of
~50IucgMOFP(BAC-)

infected cells harbouring latent genomes were reactivated.

In cultures infected with 5 pfu/cell of either virus, there was a significant drop in reactivation
frequency in cells reactivated 3d.pj,. This was likely due t.o cell death, with loss of cellular
adherence and disruption of the monolayer. Cell death did not occur in the cultures infected at
0.1 or 1 pfu/cell reactivated by 3 d.pj.

~50luc(BAC+)

cultures infected at 5pfu/cell are shown

following reactivation 3 d.pj as an example (Figure 17).
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Figure 17
Phase contrast images for 3T3 fibroblasts from experiment 17a, infected with either 0.1, 1 or 5
pfu/cell of L\.50Iuc(BAC+), and reactivated 3 days post infection. Images were taken 20h post
reactivation at lOx magnification.
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Given the toxicity effect noted following infection at 5 pfu/cell ( Figures 16 & 17) and the low
reactivation frequency observed following initial infection at 0.1 pfu/cell (Figure 16), further
latency experiments in 3T3 fibroblasts were conducted at 1 pfu/cell.

1150IucgMGFP (BAC-) and LJ50Iuc(BAC+) infected cultures are able to maintain a stable latent
state for at least 30 days

To ascertain the stability of latency following infection of cells with an ORF50 deletion mutant,
latently infected cultures were followed over 30 days (Figure 18). The level of background autofluorescence in t:.50lucgMGFP (BAC-) infected cultures remained stable at 1-2 % over the 30d
time course, indicating the absence of contaminating lytic virus. On reactivation by superinfection with 5 pfu/cell ofWT(BAC-), it was revealed that up to 37.6+/-6 % of cells harbour
latent genomes (Figure 18a).

Figure 18b shows that the HCMV -IE promoter remained active in up to 14.2 +/-1.6% of cells
infected with t:.50luc(BAC+). On reactivation, up to 47.4 +/-9.3 % of cells fluoresced green,
approximately 10% higher than t:.50IucgMGFP (BAC-) infected cultures which is likely due to
'.

differences in partic1e/pfu ratios between viral stocks (Figure 7). In the first 3d.p.i, the
proportion oflatently infected cells in which the HCMV-IE promoter is active initially decreases
as seen in Figure 16, but remains stable over the 30d time course. The absence of increasing
numbers of green cells in un-reactivated cultures indicates the absence of spontaneously
reactivating virus.
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There is some variation in the number of green cells on reactivation over the time course with a
slight increase at the 15 and 30d time points. This is likely due to small differences in viral pfu
delivered over the 3 independent experiments. A steady increase in the proportion of green cells
in PAA treated infected cultures, without reactivation, is noted. This may be due to a stimulatory
effect ofPAA on the HCMV-IE promoter resulting in GFP expression, or may represent a
reactivating effect ofPAA on latently infected virus.
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Figure 18

3T3 cells seeded at 5 x 104 cells/well were infected with either a)t.50luc gMGFP(BAC-) or
b)t.50Iuc(BAC+). These cultures were passaged every four days. Briefly, cells were detached
from monolayer with trypsiniEDTA, pelleted and resuspended in Imll0% DMEM. These
latently infected cells were counted, and seeded at 5 x 104 cells/well in fresh six well plates. Each
assay was performed in triplicate. Reactivation with 5 m.oj ofWT(BAC-) in the absence of

PM for a) and in its presence (b), occurred at 1, 2,3,5,7,15, and 30 days post infection. The
proportion of green fluorescent cells was determined by FACS for un-reactivated and reactivated
cultures at each time point. A background level of fluorescence in mock infected cells occurred
in the green fluorescence range. This value was deducted from FACS values for all infected
cultures.
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DAY 30

Latency in RAW Macrophages

While permissive 3T3 fibroblasts were appropriate in the initial characterization ofthe 1\.50
latency system, the actual sites oflatency in vivo are primarily B lymphocytes, with latency also
occurring in macrophages and dendritic cells. Thus, the next step was to explore latency
establishment and maintenance in non permissive RAW macrophages and NSO B cells.

Rhadinqvirus attachment into cells is mediated by glycosaminoglycans (GAGs), heteropolysaccharides expressed on some cell surfaces, and facilitating viral entry by providing a site
for reversible attachment [Shukla et ai, 2001]. 3T3 fibroblasts represent a permissive cell line, in
which GAGs are abundantly expressed, and viral entry is efficient. In contrast, RAW
macrophages and NSO B cells represent relatively GAG deficient non permissive cell lines
[Bemfield et ai, 1999].

The immune response to viral infection involves antibody mediated neutralization of virus to
prevent binding to cell receptors [Fink et ai, 2006] ; [Knossow et ai, 2006]. Recent studies have
shown that neutralizing antibody inhibits infection of fibroblasts, but binding to Immunoglobulin
receptors (IgFcR) on macrophages by antibody coated MHV-68 can still occur, and actually
enhances viral infection in these cells. The enhancing effect is greatest with antigp150 antibody
[Rosa et ai, 2007] ; [Iankov et ai, 2006]. Gp150 is a transmembrane glycoprotein encoded by the
ORF, M7 [Stewart et ai, 1996]. It is unclear whether this is a means by which MHV-68
circumvents the immune system, or whether the enhanced infection of immune cells is actually
part of immune activation and the host defense mechanism.
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A proposed mechanism for gp 150 action is to provide a cue for viral entry by weakly associating
to GAGs on the cell surface. The major GAG binding protein is gp70, which is thought to bind
soluble GAGs, thus hindering the premature association of gpl50 with GAGs. Gpl50 binding to
GAGs induces a conformational change, resulting in viral adsorption and entry [Gillet et ai,
2007]. Furthermore, MHV-68 down-regulates GAG expression in already infected cells, as GAG
binding to gpl50 inhibits virion release [Souza et ai, 2004]. The fact that neutralization of gpl50
enhances infection in GAG deficient macrophages and dendritic cells, and that a gp 150 deficient
mutant has enhanced infection in B cells presents a conundrum, and suggests that GAG
independent mechanisms of viral entry may occur in these cell types. IgFcR mediated
enhancement of macrophage infection can however be exploited for in vitro assays in this cell
type.

The preceding studies in 3T3 fibroblasts noted that HCMV-IE promoter activity is an unreliable
marker ofiytic or latent infection. Lippopolysaccharide (LPS) has been shown to strongly
activate the HCMV-IE promoter in RAW macrophages [Lee et ai, 2004]. In order to enhance
infection, 11-50 virus was incubated with TlAI antibody for I h at 37°C, and the antibody coated
virus used to infect RAW macrophages. On reactivation, WT (BAC-) virus at 5 m.oj was
incubated with TIAI, and then used to super-infect cultures. Given the non permissive nature of
infection, in the absence ofTIAI antibody pre-incubation, PAA was not required. 100ng/ml LPS
was added 3 hours before fluorescence imaging and flow cytometric analysis (Figure 19).
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Figure 19

Schematic Representation of Infection and Reactivation Protocol in RAW macrophages.

(t.dSO virus + antigplS0antibody)
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LPS at 100ng/ml reveals a greater proportion of the cells harbouring the MHV-68 genome
Initial experiments to demonstrate the efficacy of LPS in revealing the cohort of latently infected
cells were conducted using this infection and reactivation protocol (Figure 20).
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Figure 20
Raw macrophages were infected at! m.o.i with either ~SOlucgMGFP(BAC-) virus or
~SOluc(BAC+)

pre-incubated with gp!SO antibody. ! day post infection, cells were reactivated

with with Sm.o.i WT (BAC-) pre-incubated with gp!SO antibody. Cultures were imaged 20 h
post reactivation, in the absence or presence of ! OOng/m! of LPS
added 3h prior to F ACS.
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In the presence of LPS, a greater proportion of the latently infected cells were revealed, for·both
viruses, thus LPS was used in all further experiments in RAW macrophages. While this result is
expected for the BAC+ mutant, it indicates that LPS has other actions on the MHV-68 genome
beyond stimulation of the CMHV-IE BAC cassette, which is absent in LI.50IucgMGFP(BAC-).

As with 3T3 cells, 3 day latency experiments were conducted at MOl's corresponding to 1 and 5
pfulcell for both viruses, to assess the moi required to achieve latency in at least a third of cells in
culture (Figure 21). Given the non permissive nature ofRAW infection, an m.o.i of 0.1 was not
used.

The CMV-IE appeared to turn off over time over the 3d time course even in the presence ofLPS
with un-reactivated L'l.50luc(BAC+) (Figure 21b). Generally, there was an increase in the
reactivation efficiency for both viruses over the 3 day time course. The highest reactivation
efficiency was seen at an m.o.i of 5 for both viruses, without the toxic effect noted by day 3 in
3T3 cells (Figure 16). Both the delay in peak reactivation frequency, and the lack of a toxic
effect at 5 m.o.i are likely due to a reduced infectivity ofRAW macrophages with virus, even
with viral potentiation by gp 150 antibody. Thus an m.o.i of 5 was used for further experiments.
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Figure 21

RAW macrophages were infected at 1 or 5 pfulcell of a)~50Iuc(BAC+) or b )~50luc
gMGFP(BAC-) pre-incubated with TIAI antibody. At 1,2 or 3 days post infection, cells were
reactivated with with 5m.oj WT (BAC-) pre-incubated with TlAI antibody. The proportion of
green fluorescent cells was determined by flow cytometry 20h post reactivation for (Un)unreactivated and (R)reactivated cultures, with IOOng/ml LPS applied to cultures 3h before flow
cytometry . A background level of fluorescence in mock infected cells occurred in the green
fluorescent range. This value was deducted from FACS values for all infected cultures.
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Rl5

To assess the stability of latent infection, cells were infected with either ~50 virus and followed
over 30 days (Figure 22).

The peak reactivation efficiency in ~50luc(BAC+) and ~50IucgMGFP(BAC-) cultures was
58.54%+/- 7.82 and 51.53% +/- 1.07 respectively. There was an increase in the reactivation
efficiency for both viruses in the first three days of infection, which was however stable over the
30 days, indicating episomal maintenance oflatent genomes.

The increase in green fluorescence seen in the first 15 days of infection with
~50lucgMGFP(BAC-)

lacks the exponential quality of contaminating lytic infection, and is

likely due to auto-fluorescence, increasing somewhat as the cells grow older, despite application
of fresh media every four days on passaging (22a).

In the first 3 days of ~50Iuc(BAC+) infection, there is a decrease in green florescence in Ullreactivated cultures, and then an increase at 7 days. This likely reflects stimulation of the
HCMV - IE promoter during the change in environmental conditions imposed by passaging on
day 7 (every 4 days with day 0 being the first passage), and is in a similar range to day I (22b).

86

Figure 22

RAW macrophages were infected at 5 pfu/cell of a)L':.50IucgMGFP(BAC-) or b) L':.50Iuc(BAC+)
pre-incubated with gp 150 antibody. Cells were passaged every four days in the same manner as
3T3 cells (Figure 1) with the exception that cells were detached from the monolayer by scraping
into media. Each assay was performed in duplicate. At 1, 2,3,7, 15 or 30 days post infection,
cells were reactivated with 5m.oj WT (BAC-) pre-incubated with gp 150 antibody. The
proportion of green fluorescent cells was determined by flow cytometry 20h post reactivation for
un-reactivated and reactivated cultures at each time point, with 100nglrnl LPS applied to cultures
3h before flow cytometry. A background level of fluorescence in mock infected cells occurred in
the green fluorescent range. This value was deducted from FACS values for all infected cultures.
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Latency in NSO B cells

t150Iuc(BAC+) has a reactivation efficiency of only 2% using the established protocol

MHV -68 infects B cells with low efficiency [Bemfield et ai, 1999]. Unlike macrophage infection
however, antibody treatment does not enhance infectivity of B cells, nor does LPS reveal latently .
infected cells (Stevenson, personal communication). To examine latency in B cells, the protocol
of Ll.50 infection followed by reactivation was employed at high m.oj, comparing the BAC+
viruses, M7 stop mutant (Ll.M7, BAC+)and WT(BAC+) virus to Ll.50Iuc(BAC+) as positive
controls. BAC+ viruses were used so that they could be directly compared for green fluorescence
over the time course. Ll.M7 was used as a positive control as this mutant has an enhanced ability
to infect B cells [de Lima et ai, 2004]. WT (BAC+) was used to determine whether the
D.50Iuc(BAC+) had any greater deficit over WT in infecting B cells. Reactivation by WT (BAC-)
virus superinfection at 5 pfulcell was performed 48 h.pj and samples analyzed for GFP
expression by flow cytometry. 18% of Ll.M7(BAC+) infected cells and 11 % ofWT(BAC+)
infected cells were reactivated, whereas only 2% of Ll.50Iuc(BAC+) cells were reactivated
(Figure 23). The protocol applied to 3T3 fibroblasts and RAW cells could thus not be
extrapolated to B cells which have a low efficiency of infection, limiting both infection and
reactivation efficiency. Furthermore, B cells are preferentially latently infected, thus WT (BAC-)
virus used for super-infection, is likely to go latent, and fail to reactivate quiescent genomes.
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Figure 23

Comparison of green fluorescence in NSO cell cultures infected with either L'. 50luc(BAC+) at
1,3,5, 7 or 10 pfulcell, WT(BAC+) at 3, 5 or 7 pfulcell or L'.M7 (BAC+) at I and 3 pfulcell.
Given the poor infectivity ofB cells, a range ofmoi ' s was used to determine how much virus
was needed to infect a substantial population of B cells. Latently infected cultures were
reactivated at 48 hours post infection, by infection with 10 pfulcell of WT (BAC-). Cells were
imaged 20h post reactivation by fluorescence microscopy and analysed by flow cytometry for
green fluorescence. A background level of fluorescence in mock infected cells occurred in the
green fluorescent range. This value was deducted from FACS values for all infected cultures.
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L15 Oluc(BA C +) populations have low, variable GFP expression profiles even after FA CS sorting

In order to examine latency in NSO B cells, FACS sorting was utilized to generate enriched
populations of infected cells. NSO cells were infected at 10 pfulceU with D.50Iuc(BAC+), and
sorted 48 h.p.i into GFP positive and GFP negative populations (Fignre 24). FACS sorting
revealed that 2.7% of cells expressed GFP, with enrichment to generate a population where 95%
of cells were GFP positive. These populations were followed over the course of 14 days by
fluorescence microscopy, and FACS analysis was used to measure GFP expression 7 and 14
days following sorting. By 7 and l4dpi, 23% and 16% of the initially GFP positive population
fluoresced green, while 3% and 7% of the initially GFP negative population showed green
fluorescence. Thus HCMV-IE promoter expression was variable, but low, in both the GFP
positive and GFP negative sorted populations over time (Figure 25).

"
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Figure 24

FACS Sorting ofNSO cells infected with t.50luc(BAC+) at 10 pfu/cell and sorted 48 h.p.i. PI is
the region containing the sorted population of cells to achieve 95% of GFP positive cells (P3). P2
represents the GFP negative population sorted, while Not PI shows the unsorted population.
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Figure 25

NSO cells were infected at 10 pfu/cellwith L'>50Iuc(BAC+), and sorted 48 h.p.i into GFP positive
and GFP negative populations on day 0, with 95% of cells in the GFP population fluorescing
green, and no green fluorescence noted in the GFP negative population. Cultures were then
subjected to flow cytometric analysis for green fluorescence at 7 and 14 days post infection. A
background level of fluorescence in mock infected cells occurred in the green fluorescence range.
This value was deducted from FACS values for all infected cultures.
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In summary, latency was established in 3T3 fibroblasts and RAW macrophages and successfully
maintained over 30 days, with comparable reactivation efficiencies achieved by infection with 1
and 5 pfu/cell of Ll.50 viruses in the respective cell lines. NSO cells had a very low reactivation
efficiency thus FACS sorting was utilized to generate enriched latently infected populations.
These reactivation efficiencies of the Ll.50 viruses in these three cell lines are summarized in
Table 5.

Table 5
Reactivation efficiencies of 3T3 fibroblasts, RAW macrophages and NSO B cells infected with
Ll.50 viruses at 1, 5 and 10 m.oj for the respective cell lines.

Cell Type

Virus

Reactivation
Efficiency (%)

3T3

RAW

NSO

Ll.50luc(BAC+)

I 47.4 +/-9.3

Ll.50lucgMGFP(BAC-)

37.6+/-6

Ll.50luc(BAC+)

58.54+/- 7.82

Ll.50lucgMGFP(BAC-)

51.53 +/- 1.07

Ll.50luc(BAC+)

2.0
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DISCUSSION

In long-term experiments exploring latency, it is important to be able to visually screen cultures
for lytic infection. A GFP based repOlter system in which lytically and latently infected cultures
have distinct fluorescence patterns is an ideal prelude to more sensitive assays. The
Ll.50IucgMGFP(BAC-) virus proved superior to Ll.50luc(BAC+) in this respect, as both latently
and lytically infected cultures may exhibit green fluorescence in the latter case (Figure 10). GFP
expression also provided an amenable means to measure reactivation efficiency, and thus
indirectly assess the proportion of latently infected cells in culture. With approximately 40-60%
of 3T3 fibroblasts and RAW macrophages latently infected at I and 5 pfu/cell of Ll.50 virus in the
respective cell lines (Figures 16 & 21), a sufficient proportion of cells are latently infected to
yield biological material for assays such as Real time PCR.

While the luciferase gene was initially cloned out of frame, a Ll.50luc mutant became available at
the conclusion of this thesis, with the in frame luciferase confirmed, showing inducibility of the
ORF50 promoter in lytic infection, as indicated by luciferase expression (Connor, personal
communication).

Having shown that latency can be established and maintained within the

Ll.501uc system, luciferase assay under various conditions would prove u.seful in elaborating
existing knowledge of biochemical agents and environmental conditions regulating the ORF50
promoter. For example, LPS appeared to effect GFP expression, even in the absence of a BAC
associate HCMV IE promoter, indicating that it has other actions beyond stimulation of this
promoter (Figure 20).
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In addition, 3T3 cultures infected with D.50Iuc(BAC+) and treated with P AA without
reactivation, showed increased green fluorescence over cultures infected with D.50Iuc(BAC+)
alone, suggesting an action on either the HCMV-IE promoter, or some basal activation of the
viral genome (Figure 18). Luciferase assays in the presence ofLPS or PAA could reveal if these
agents stimulate the ORF50 promoter.

In both 3T3 fibroblasts and RAW macrophages, the reactivation efficiency is stable over the 30
days (Figures 18 & 22). This indicates that episomal maintenance of D.50 genomes is occurring,
with the genome being passed on with each cell division [Husain et ai, 1999). FurthelIDore, the
ability to reactivate the GFP expressing D.50 mutants on donation of ORF50 by WT (BAC-) is an
indication that the viral genome is latent in the cell [Wu et ai, 2000).

3T3 and RAW cells had comparable maximal reactivation efficiencies with both D.SOJuc(BAC+)
and D.SOlucgMGFP(BAC-) virus over 3 day and 30 day time courses. However, an increase was
noted in the proportion of reactivated cells for both viruses in RAW cells from 1 to 2 days in the
three 'd ay time course, suggesting that there is a lag in D.SO entry into RAW macrophages, also
documented with WT MHV-68(Stevenson, personal communication).
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Previous latency systems have been confounded by contaminating replication competent virus.
In tbe S 11 cell line, 1% of cells are productively infected, contributing abundant lytic transclipts
[Husain et ai, 1999]. In this latency system, no exponential increase in green fluorescence was
seen over 30 days in un-reactivated cultures, indicating the absence of contaminating lytic virus.
RAW macrophages infected with ~50lucgMGFP(BAC-) did show a mild increase in green
fluorescence in un-reactivated cultures in the first 15 days of infection (Figure 22). The
~50IucgMGFP(BAC-) virus has a high particle to pfu ratio (2.4 xlO 4 :1), and the presence of

many defective particles may have contributed to a hostile environment for the cells, or directly
contlibuted to auto-fluorescence. Transcliptional assays would prove useful in clalifying whether
there is indolent productive infection.

B cell infection is a rare event in vivo, however it is the proliferative capacity of tbis cell type
that generates substantial reservoirs of latent virus [de Lima et ai, 2004]. Over the 14 day time
course, the proportion of green fluorescent cells in tbe GFP positive sorted B cell population
actually decreased from 95% down to 16% in 14 days (Figure 25). This may be due to the
HCMV-IE promoter shutting off over time, and the fact that GFP negative sorted populations
went from 0 to 7% green fluorescence indicates that HCMV-IE promoter activation is valiable in
latently infected cells. The possibility that tbe decrease in green fluorescence in GFP positive
sorted cells is due to loss of viral genomes cannot be excluded at this point [Ciufo et ai, 2001].
Transcliptional analyses would indicate if this were the case. Furthermore, other reactivation
protocols can be explored for B cells. For example, TSA has been used to reactivate latent
genomes [DeWire et ai, 2005].
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While the maintenance oflatency at distant time points could be confinned in 3T3 fibroblasts
and RAW macrophages by reactivation with WT(BAC-), this reactivation protocol could not be
applied to NSO cells given their poor infectivity (Figure 23). However, other reactivation
protocols can be explored, such as the use of TSA.

These preliminary latency experiments indicated that the Ll50 latency system appears to be a
clean latency system, although transcriptional analysis is required for confilmation.
Characterization of the transcriptional profile of the latent Ll50 genome will provide the
groundwork for future explorations into latency. With a clean latency system at hand, the
establishment of a latent cell line carrying latent Ll50 genomes would allow the search for novel
latent transcripts.

Thus, the next step was a transcriptional analysis of the Ll50 latency system.
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CHAPTER 3

Transcriptional Analysis ofthe MHV-68 A50 Latency System
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INTRODUCTION

The peR reaction is based on the exponential copying of template DNA or cDNA to produce
quantifiable amounts of genetic material. The amount of original template is then determined by
backward extrapolation [Higuchi et ai, 1993]. The amplification of the small amounts of RNA
isolated in biological assays presents a highly sensitive assay for determining whether lytic
transcripts are present, and the ability to compare the relative abundances of latent transcripts
over the observed time course. The relative amount of each transcript corresponds to the relative
expression of each gene tested under the given conditions.

Real time polymerase chain reaction CRT-peR) measures gene products over the linear range of
amplification as they accumulate, and is preferable to end point measurements which show
greater intra-assay variability, and less sensitivity [Schmittgen et at, 2000] . The real time peR
assay is described in Figure 26.
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Figure 26

A typical TaqMan probe containing a 5' dye molecule, 6-carboxyfluorescein (6-FAM) and a 3'
quenching molecule, 6-carboxy tetramethyl rhodamine (TAMRA) with an intervening sequence
complementary to the DNA of interest, allowing the probe to hybridize to the template between
the 5' and 3' PCR primers. The proximity of TAMRA to 6-FAM in the molecule allows
TAMRA to quench the fluorescence signal of the 6-FAM dye by Forster-type energy Transfer.
During DNA replication, the 5' nuclease activity ofTaq Polymerase cleaves the probe only if the
probe is hybridized to the target DNA, thus preventing non specific amplification, and separates
the reporter and quencher moieties, thus allowing the reporter dye, 6-FAM to fluoresce fully.
Accumulation of PCR products is detected by monitoring the increase in fluorescence of 6-FAM
[Heid et ai, 1996] ; [Mackay et ai, 2002]. The fractional number of PCR cycles required to
generate enough signal to reach a fluorescent signal threshold determined during the exponential
phase is defined as the cycle threshold (Ct), is directly proportional to the amount of starting
template and thus allows the direct comparison of different gene products. Adapted from
[Ginzinger 2002].
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Figure 27
A Hypothetical Amplification Plot

The amplification plot is the plot of fluorescence signal verus PCR cycle number. The baseline
is defined as the PCR cycles in which a signal is accumulating but is beneath the limits of
detection of the instrument. The signal measured during these PCR cycles is used to plot the
threshold (dotted line). The threshold is calculated as 10 times the standard deviation of the
average signal of the baseline fluorescent signal. A fluorescent signal that is detected above the
threshold is considered a real signal that can be used to define the threshold cycle (Ct) for a
sample. The Ct is defined as the fractional PCR cycle number at which the fluorescence signal is
greater than the minimal detection level. The Ct values of different samples are then used to
calculate the relative abundance of template for each sample. Adapted from Applied Biosystems
DNAIRNA Real-Time Quantitative PCR Bulletin.
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In order to ascertain the reproducibility of data, individual reactions are run in triplicate, in
addition to performing biological replicates. The use of negative template controls screens for
non-specific signal due to template contamination or primer dimers [Nolan et ai, 2006]. Absolute
quantification of RT-PCR generated data is enabled by the parallel amplification of known
concentrations of target DNA at a range of serial dilutions falling within the exponential phase of
the amplification reaction, to generate a standard curve [Rutledge et ai, 2003 ] ; [Larionov et ai,
2005]. Use of housekeeping genes as an internal control enables normalization of data, reflecting
total RNA isolated from each preparation and taking into consideration total RNA degradation
kinetics. 18s rRNA has been proven to be the most constant house keeping gene [Port et ai,
2007].
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Selection of Transcripts for RT-PCR

Previous in vitro and in vivo studies have identified latency associated and lytic transcripts of
MHV-68. A review of the literature was conducted in order to select representative lytic and
latent transcripts for application in RT-PCR assays (Table 6).

Initial searches for latent transcripts in MHV-68 based on known latency associated genes in
other gammaherpesviruses, revealed three distinct regions that were transcriptionally active
during latency, in splenocytes or periteoneal macrophages derived from B cell deficient mice.
The region encoding M2 and M3 , produced M2 transcript in both cell types. In the region
encompassing ORFs 73 and 74, transcripts were present in latently infected peritoneal cells
[Jacoby et ai, 2002].
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Table 6

Lytic and Latency associated genes, their functions and pathogenesis deficit in MHV68.
Provided by Efstathiou, S.E (Personal Communication). The functions of confirmed MHV -68
genes, where known, are related to the phenotype associated with knockout mutants. Genes
homologous to Herpes simplex virus are shown in bold, and brackets indicate that gene function
has been determined by homology. ND indicates not determined. References are listed.

Gene
Ml
M2
M3
M4
ORF4
ORF8
ORF9
ORFll
K3
13M
ORF21
ORF22
ORF27
ORF28
ORF39
ORF47
ORF50
ORF51
ORF53
ORF58
ORF65
ORF72
M9
MIl
ORF73
ORF74

Biochemical function

Pathogenesis deficit

ND
inhibits effects of interferon
Secreted chemokine binding protein
ND
Complement control protein

Enhanced ex vivo reactivation

ND
Lytic replication deficit

Reduced acute latency, increased long-term latency
Reduced latency amplification and intracerebral pathogenicity

gB, cleaved virion protein, receptor binding

Essential in vitro

Viral DNA polymerase

Severe lytic replication deficit

tegument protein

Lytic replication deficit

Degrades MHC class I and TAP

ND
(capsid component)
(cyclin D homolog)

latency amplification deficit
ND
Severe lytic replication deficit
Essential in vitro
Lytic replication deficit
No deficit
Essential in vitro
ND
Essential in vitro' overexpression ablates latency
release deficit in vitro, normal repJication in vivo
ND
ND
ND
Reduced ex vivo reactivation

Viral capsid
bcl-2 homolog, anti-apoptotie

Reduced latency amplification and pathogenicity

ND
thymidine kinase
(glycoprotein H, virion fusion protein)
Virion glycoprotein, cell / cell spread
high glycosylated virion protein

-

Gm, heterodimer with gN
(Gl, heterodimer with gH)
lytic cycle transcriptional activator
gp150, virion protein
gN, heterodimer with gM

(episome maintenance)

Severe latency deficit

chemokine receptor

Reduced ex vivo reactivation
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M2 has consistently been shown to be expressed in latency in a range of cell types in vivo arid in
vitro [Jacoby et ai, 2002] ; [Martinez-Guzman et ai, 2003]. This makes it an ideal transcriptional
marker for latency. ORF73 encoding LANA is also an ideal transcript to use in studying the
course of a latent infection, given its established role in episomal maintenance [Ballestas et ai,
1999] ; [Lan et ai, 2004]. Microarray analyses oflatently infected SII cells indicated that
ORF73 is the most abundantly produced latent transcript, with 13 fold greater expression than
M2. As an immediate early transcript, ORF73 is also expressed dUling lytic infection [MartinezGuzman et ai, 2003], while M2 is transcribed at very low levels during lytic infection.

A third region encoding M9, homologous to the HVS ORF65 capsid protein, was identified as
transcriptionally active during latency [Jacoby et ai, 2002]. M9, is produced only in splenocytes
during latency, but produced abundantly during lytic infection in vitro [Martinez-Guzman et ai,
2003]. M9 transcripts have been detected in latently infected SII B cells [Husain et ai, 1999]. It
is unclear whether this represents low level lytic replication or a role for M9 in latency .The
transcriptionally active region identified by RT-PCR may represent a long latent transcript
spanning M9 rather than M9 specific transcription.

The time course of expression of these genes has been characterized in vitro in lytic infection
[Martinez-Guzman et ai, 2003]. Multiple transcription patterns are possible during latency in
vivo, in different cell types, thus an in vitro latency system in which defined cell types can be coordinately infected and transcription patterns analyzed would be of great utility [Simas et ai,
1998].
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ORF73 peaks within 8 h.p.i while M2 peaks within 32 hours in BHK-21 cells [MartinezGuzman et ai, 2003]. M2 is necessary for reactivation from latency in vivo. Specifically, M2
appears to be required for the efficient colonisation of splenic follicles [Simas et ai, 2004]. With
a role in reactivation from latency, it is unsurprising that M2 is also expressed, albeit at very low
levels, during lytic infection [Herskowitz et ai, 2005] . As an immediate early transcript, ORF73
expression during lytic infection is expected [Martinez-Guzman et ai, 2003].

Of the potential representative lytic transcripts, M9 is the most abundant in lytically infected
BHK-21 and 3T3 fibroblast cells making it ideal for inclusion in this analysis
[Rochford et ai, 2001] ; [Martinez-Guzman et ai, 2003]. While it is detected at low levels at 1
h.p.i, its transcription peaks late in infection (24 h.p.i), and is also detected during latency. For
an unambiguous lytic marker present abundantly throughout the lytic time course, the ORF 9
(DNA Polymerase) transcript was also selected [Ebrahimi et ai, 2003].

Finally, in order to characterize the ORFSO null mutant at the transcriptional level, the ORFSO
immediate early lytic transcript was included in this study, allowing for a comparison of wild
type to 1\.50 MHV -68 expression kinetics across a range of cell types. The 1\.50 deletion does not
encompass the entire ORFSO transcriptional unit, thus primers have been designed to detect the

-.

undeleted regions of the primary transcript (Coleman, personal communication).
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METHODS

Viral DNA Purification and Quantification

For RAW macrophages, 5x 104 cells/well were seeded in a 6 well plate and grown to 70%
confluence overnight. Cells were infected with 10 pfu/cell of t.50IucgMGFP(BAC-). Cultures
were incubated for I, 2, 4, or 6 days with 10% DMEM. For NSO B cells, infected cultures were
sorted into GFP positive and GFP negative populations by FACS.

Infected cultures were

incubated for 7 days with 10% DMEM. To harvest DNA, cells were rinsed with PBS, and 250ul
i

ofTE buffer (lOmM Tris: 50mM EDTA, pH8). 25 III of 10% SDS and IIl120mgmr proteinase
K were added to samples, and incubated at 37°C overnight. Samples were sonicated for 2 x I
min to generate DNA pieces 5-6Kb in size. DNA was purified according to the Qiaquick PCR
Purification kit (Qiagen) protocol. DNA concentration was determined using the ND 1000 UV
Vis Spectrophotometer (Nanodrop).

DNA samples were subjected to real time PCR with HotStar Taq (Qiagen) using TaqMan probes
and the relevant primer sets using the Rotor Gene RG 3000 (Corbett Research). PCR products
were quantitated alongside a standard curve of cloned template from purifie(!.plasmid dsDNA for
each transcript, which are listed in table 7.
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RNA Isolation

For all cell lines used, 5x 104 cells/well were seeded in a 6 well plate and grown to 70%
confluence overnight. Cells were infected with either I pfulcell of l'.50lucgMGFP(BAC-) or WT
virus. Given the high particle to pfu ratio, t.5OlucgMGFP(BAC-) was also used at 10 pfulcell.
RNA was extracted from infected cells according to the manufacturer's instructions for the RNA
aqueous 4 PCR ™ kit (Ambion). Reagents are listed in appendix 2. Briefly, cells were washed
with Ix PBS, and 300/-11 of lysis solution were added. Cells were scraped from the monolayer
into solution, and collected into 1.5ml eppendorf tubes. Samples were vortexed, and an equal
volume of 64% ethanol added. Samples were applied to filter cartridges and subjected to serial
washes. Cartridges were placed in fresh collection tubes and eluted in 60 /-11 of hot elution
solution. RNA concentration was determined using the ND 1000 UV Vis Spectrophotometer
(Nanodrop). RNA samples were stored at -70°C.

PolyA+ Selection ofmRNA from total RNA

mRNA was selected from total RNA using the Micro PolyA Purist ™ kit (Ambion). 5/-Lg of
RNA was diluted in RNA storage solution (Ambion) to a total volume.. of 250/-L1. An equal
volume of 2X binding solution was added. The RNA sample was applied to oligo-dT Cellulose
resin (Ambion), and mixed thoroughly. Incubation of the mixture for 5min at 75°C was followed
by gentle agitation on a rotator for Ih to ensure RNA binding to resin.

112

Resin was pelleted by centrifugation at 4,000xg in a pi co microfuge (Heraeus) for 3 min at RT,
and applied to a spin column, with serial washes performed to remove non-specifically bound
material and ribosomal RNA from the resin.

PolyA +RNA was recovered in a fresh collection tube by elution with 200Jll elution solution
(Ambion) at 75°C, and centrifuged at 5000g x2 min in a pico microfuge (Heraeus) PolyA+ RNA
was precipitated with 20 Jll of 5M Ammonium acetate, 1Jll of 5mglml glycogen, and 550 Jll of
100% ethanol. RNA samples were stored at -70°C.

DNAse treatment of RNA

RNA was subjected to Turbo DNAse (Ambion) treatment to eliminate any contaminating DNA
in samples prior to reverse transcription to generate eDNA. 4 Jll of 10xTurbo DNA buffer and
0.5 Jll of 2U/JlITurbo DNAse was applied to 40 Jl1 RNA samples and 40 Jll mRNA samples.
Samples were incubated for 30min at 37°C. An additional 0.5Jll of Turbo DNAse was added to
samples with a further 30min incubation. 12.5Jll of DNAse Inactivation Agent (Ambion) was
added and incubated for 2min with mixing, followed by centrifugation at 1O,OOOxg for 1.5min to
precipitate the inactivation agent. RNA samples were stored at -70°C.
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Reverse Transcription of RNA

RNA samples were reverse transcribed to generate cDNA template to be used for RT-PCR, using
the MessageSensor RT kit™ (Ambion). Duplicate preparations of O.S J.lg RNA template in 4J.ll
aliquots, 3.S J.ll of primer supermix containing equal volumes of all 7 primers at 10J.lM
each(Table 6), and 4.SJ.ll of water were made, and denatured at 6S0C for Smin in a Thermal
Cycler (Bio-Rad). A minus template control was prepared by substituting 4J.ll of nuclease free
water for the RNA template.

8J.ll of an RT master mix containing 2J.ll lOx RT-PCR buffer, 4J.ll dNTPmix (containing 2.SmM
each of dATP,dTTP, dGTP and dCTP), 2J.ll of 10UIul RNAse inhibitor(Ambion) and 2J.ll ofMMLVRT was then added to each RT sample. 4ul of the 2.5mM d.NTP mix and 4ul water were
applied to the corresponding minus RT controls. Primer extension occurred at SO°C for 60min,
and M-MLVRT denaturation at 9S °Cfor 10 min, to prevent illegitimate reverse transcription
duringPCR.

Real Time peR on eDNA template

A supermix containing the appropriate primer set and TaqMan Probe, 2Sm.M MgCh to the final
concentrations shown in table 8 was prepared. Reactions were optimized by Dr Coleman, with
the appropriate combination of 2.SmM dNTP mix, lOX PCR buffer (Qiagen), 0.4 Ulul Taq
Polymerase (Qiagen) and nuclease free water added for each primer set.

114

12111 of supermix was dispensed to sample tubes, and 8111 of cDNA template added to a final
volume of 20111. Standards were prepared by adding 48111 of supermix to 28 III of H2 0 and adding
4111 of DNA to make 3 x 20111 aliquots for triplicate reactions. Standards were made by serial
dilution of DNA plastnids listed in Figure 7, in salmon sperm DNA to generate standards ranging
from 10° to 10 10 copies/ill. Denaturation was performed at 95°C x 15min. Cycling parameters
were 95°C x 15sec, and 60°C x 60sec for 45 cycles.
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Table 7

Primer sets used for RNA and DNA Quantification by RT - peR
(F) =(S) and denotes the forward/sense primer reading in the 5'to 3' direction
(R)= (A) and denotes the reverse/antisense primer reading in the 3' to 5' direction
TM denotes the Taqman Probe, an oligomer containing a sequence complementary to the DNA
in question and containing the 5' dye 6-carboxyfluorescein(6-FAM) and the quenching molecule
6-carboxy tetrarnethyl rhodamine (TAMRA)
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MHV-68

TaqmanMHV-6~

promoter

sequence

sequence

region

coordinates

coordinates

(A)

(F)

20844-20825

5'CTgATTTgATggCAggATgTAgTTC

20716

(S)

(R)

5' -ggTgCTgACTgATggACA

20825

MHV-68

ORF9

Standard Plasmid

Primer ffaqman Probe Sequence

PEcoRV-H in pSP73

promoter

20695-

20890-

TM5'
6F AM-CTCCTggCAgCgTCgAgCAA-TMR
M9

M2

p.BAMHI-F in pUCl3

p.HIND

III

E

in

pUCI3

(F) 5' CTAAAgCTgTTCCCgTCAgACAT

(F)

(R) 5'gTCCCTTCCTCTTCTggAgCAT

94075

TM5'

(R)

6FAM-AgCACAAAACCCAgTCCAgACTTgTCA-TMR

94204

(R.)

(S)

5' ATCT ATgAAACTgCT AACAgTgAACC

4188

(S)

(R)

5'gTCAgTCgAgCCAgAgTCCAAC

4228

94053-

94096-94122

94225-

4166-

42 19-4 189

4252-

TM5'
6FAMCCAgCCAATCTCTACgAggTCCTTAATgA-TMR
Ort73

BAMG in p.ACYCI84

(F)

(F)

5'TgTggATggCTgCTCgg

104047-

104079-104104

104063
(A) 104173104153

(A)
5'ggTTgTCTTggCCTACTgTgAA
TM5'
6FAM5'CTgTAggggggCTCTggT AAgggAAAA- TMR
ORF50

p.REVTRE.ORF50

(F)

(F)

66779-

5' CCCCTTCAgCCgATAAggAC

66795,

(R.)

67661-67664

5' CAgggTgCTgTAggAAgCAT

(R)

TMS'

67756

67775-

6FAM-AACTggCTCAAgTAgACCTgCTTCgATCC-

BBQ
Murine
18S

(F)Cgg CT A CCA CAT CCA Agg AA

p.GEMEASY-T

with

an

2004

insert

corresponding to the

Radonic et ai,

(R) gCTggAA TTACCgCggCT

peR product

TM5'
6FAM-CgCAAATTACCCACTCCCgACCC
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67698-67670

Table 8 Primer, TaqMan Probe and MgCI, Concentrations used in Real Time RT-PCR

Primer Set

Reagents

Final Concentration nM

ORF9

F primer

900nM

R primer

SOnM

TaqM an Probe

SOnM

MgCI,

4.SmM

F primer

SOOnM

R primer

SOOnM

TaqMan Probe

SOnM

MgCl,

S.SmM

F primer

SOnM

Rprimer

900nM

TaqMan Probe

SOnM

MgCl,

3.5mM

F primer

SOnM

A primer

900nM

TaqMan Probe

SOnM

MgCI,

3.SmM

F primer

900nM

Rprimer

300nM

TaqMan Probe

SOnM

MgCl,

3.SmM

F primer

SOnM

Rprimer

SOnM

TaqMan Probe

2SnM

MgCl,

4.5mM

M2

M9

ORF73

ORF SO

Murine l8S ribosomal RNA
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RESULTS
Latency experiments showed that the two
in 3T3 and macrophage cells, but that

~50

viruses had comparable reactivation efficiencies

~501ucgMGFP(BAC-)

was superior to

~50luc(BAC+)

distinguishing between latent and lytic infection (Chapter 2). To characterize
transcriptional level, clone 11 cells were infected with

~501ucgMGFP(BAC-),

~50

in

at the

and compared to

WT as shown in Figure 28.

Ribosomal RNA presents a reliable internal standard as it is constitutively expressed at similar
levels in different cell types, and levels in cultured cells do not vary significantly in response to
viral transformation or altered environmental conditions [Goidin et ai, 2001]. Normalization of
each transcript to 18S rRNA transcript at each time point enabled correction for variation in total
RNA yield and in the cDNA yield from the reverse transcription step.

In Clone 11 cells infected with WT (BAC+), the total RNA yield was relatively stable over 24
hours, with 18S transcript number starting to decrease slightly secondary to cell death, as seen in
figure 10. The lytic transcripts M9, and to a lesser extent ORF50 and ORF9, were highly
expressed throughout the 24 hour time course. The latent transcripts M2 and ORF73 were
expressed at low levels initially, but increased by 2 logs by 24 h.pj potentially reflecting the
transcriptional profile ofa subset of infected cells destined for latent infection (Figure 128).
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Figure 28

Clone 11 cells seeded at 5 x 10 4 cells/well in the presence of 1.0 mglml of doxycycline, were
infected with 1 pfu/cell of either WT(BAC+) or L'.50lucgMGFP(BAC-), were harvested at 5,12
and 24 h.p.i for RNA. 0.511gofRNA was reverse transcribed, and the RT product subjected to
Real time PCR against a primer specific standard curve. The transcript copy numbers for each
sample was deducted from minus RT controls, and normalized to 18S transcript numbers at the
corresponding time point. The transcriptional profile oflatent (M2, ORF73) and lytic (M9, ORF9,
ORF50) transcripts are compared.
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Overall, the transcriptional profile of L\.50lucgMGFP(BAC-) closely resembled WT (BAC+)over
the 24 hours, with respect to the relative transcript peaks. In conjunction with single step growth
curves (Figure 6), this result indicated that L\.50IucgMGFP(BAC-) is fully complemented in the
clone 11 cell line.

Transcription profiles were compared in 3T3 fibroblasts and RAW macrophages following
infection with L\.50IucgMGFP(BAC-). Initial experiments conducted at 5 pfu/cell with
L\.50lucgMGFP(BAC-) virus in RAW macrophages gave very low Real Time PCR readouts,
thus experiments were conducted at 10 pfu/cell of L\.50lucgMGFP(BAC-) which resulted in
comparable transcript yields to those attained in 3T3 cells ( Figures 29 & 30).
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Figure 29

3T3 fibroblasts were infected with 1pfu/cell of either a) WT(BAC+) or b) il50IucgMGFP(BAC-),
and harvested at 5,12,24,48, and 72 h.p.i for RNA. O.5J.lg of RNA was reverse transcribed, and
the RT product subjected to Real time PCR against a primer specific standard curve. The
transcript copy numbers for each sample was deducted from minus RT controls, and normalized
to 18S transcript numbers at the corresponding time point. The transcriptional profile of latent
(M2, ORF73) and lytic (M9, ORF9, ORF50) transclipts are compared.
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With WT (BAC+) MHV-68 infection oOT3 fibroblasts, there was an increase in all viral
transcripts over the first 24 hours, with the latent transcripts M2 and ORF73 expressed at the
lowest levels, M9 expressed up to 3 logs higher, and ORFSO and ORF9 again showing
intermediate levels of expression.

With I\.SOlucgMGFP(BAC-) infection oOT3 fibroblasts over the 72 hour time course, there was
an increase in the number of cells as inferred from the increase in 18S transcript yield (Figure
29b. Except for ORFSO, the extent of latent transcript expression is high in I\.SOlucgMGFP(BAC-)
infected 3T3 cells in proportion to the lytic transcripts at each time point. Given the dual
objectives of remaining undetected by the immune system while maintaining the viral genome in
latently infected cells, it is ideal for latent transcripts to be expressed at low absolute levels.

In contrast to data obtained following infection of3T3 cells where viral transcripts peaked within
24 hours, there was an overall increase in both latent and lytic transcripts over the 48 hour time
course in RAW macrophage infection (Figure 30). This is consistent with the lag in I\.SO entry
into RAW cells noted by flow cytometric analyis (Figure 21).

12S

Figure 30

RAW macrophages were infected with either a) 1 pfu/cell ofWT(BAC+) orb) 10 pfu/cell
~50IucgMGFP(BACc)

viruses pre-incubated with anti gp150 antibody, and harvested at 5, 12,

24, 48, and h.pj for RNA. 0.5 ~gofRNA was reverse transcribed, and the RT product subjected
to Real time PCR against a primer specific standard curve. The transcript copy numbers for each
sample was deducted from minus RT controls, and normalized to 18S transcript numbers at the
corresponding time point. The transcriptional profile oflatent (M2, ORF73) and lytic(M9, ORF9,
ORF50) transcripts are compared.
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M2 expression was lower than ORF73 expression in the first 24 hours ofRAW
L\.50IucgMGFP(BAC-) infection, similar to the overall trend with 3T3 infection, but surpassed
ORF73 during the 24 c 48 hour time point. The lytic transcripts M9 and ORF9 were 5-6 logs
higher in the WT scenario than L\.50IucgMGFP(BAC-) over the 48 hour time course. The peak
transcript copy numbers and the times at which they occur for latent infection with
L\.50IucgMGFP(BAC-) in both cell lines are listed in table 9.

Table 9
Peak viral transcript copy numbers and time of peak (h.p.i) are shown for
3T3 fibroblasts and RAW macrophages latently infected with L\.50IucgMGFP(BAC-) at 1 and 10
pfu/cell in the respective cell lines.

CELL
TRANSCRIPT

LINE
ORF73

M2

ORF9

M9

ORF50

Peak

time

peak

Time

peak

time

peak

time

Peak

time

3T3

2.6

5

2.0

12

2.1

12

1.2

24

3.8

24

RAW

2.3

24

3.7

24

2.6

24

0.9

24

2.0

24
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Reactivation of latent genomes showed that the viral genome was being maintained over the
course of 30 days (Figures 18 & 22). In RAW macrophages, a slight increase in fluorescence had
been noted over the first 15 days oflatent infection. To dete=ine whether this was increase was
due to indolent lytic infection, and to dete=ine the transcriptional profile in long te=
maintenance of latency, the transcriptional profile in the 1'.50 latency system over the course of
30 days was examined in both 3T3 fibroblasts and RAW macrophages as shown in figures 31
and 32 respectively.

These analyses focused on the latent transcriptsM2 and ORF73, and the lytic transcript ORF9,
which showed a more distinct pattern of transcription between latent and lytic infection than the
lytic transcripts M9 or ORF50 (Figures 28-30), and was thus anticipated to provide a more
rigorous transcriptional marker oflatent or lytic infection.
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Figure 31

3T3 fibroblasts seeded at 5 x 104 cells/well in a six well plate were infected with 5 pfulcell of
!l.50IucgMGFP(BAC-), and harvested at 1, 5,10,15,20,25 and 30 days post infection, for RNA.
Cells were passaged every four days from the day of infection, and re-suspended at 5 x 104
pfulwell. 0.5llgofRNA was reverse transcribed, and the RT product subjected to Real time PCR
against a primer specific standard curve. The transcript copy numbers for each sample was
deducted from minus RT controls, and normalized to 18S transcript numbers at the
corresponding time point. The transcriptional profile oflatent (M2, ORF73) and lytic (ORF9)
transcripts are compared.
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30

Figure 32

RAW macrophages seeded at 5 x 104 cells/well in a six well plate were infected with
10 pfu/cell of ~50IucgMGFP(BAC-), and harvested at I, 5, 10, 15,20,25 and 30 days post
infection, for RNA. Cells were passaged every four days from the day of infection, and resuspended at 5 x 104 pfu/well. 0.5f!gofRNA was reverse transcribed, and the RT product
subj ected to Real time PCR against a primer specific standard curve. The transcript copy
numbers for each sample was deducted from minus RT controls, and normalized to 18S
transcript numbers at the corresponding time point. The transcriptional profile of latent (M2,
ORF73) and lytic (ORF9) transcripts are compared.
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In 3T3 cells over the 30 day time course, the cellular and latent transcripts are relatively stable.
This suggests that the viral genome is passed on with each cell division, consistent with the
relatively stable expression of ORF73 and its role in episomal maintenance. The mild
fluctuations in transcript number likely represent viral genome responses to changing
environmental conditions with each passage performed every four days. ORF9 has negligible
expression over the 30 day time course (Figure 33). If any background level oflytic virus was
present, over the 30 day time course, ORF9 expression would increase significantly.

A comparable transcriptional profile is seen in RAW macrophages over the 30 days, although
M2 expression is higher in RAW macrophages (Figure 32). This may reflect a more efficient
regulation of latent transcripts in RAW macrophages which are a site if latent infection in vivo
unlike fibroblasts. ORF9 expression was variably low, with no exponential increase noted over
the time course, indicating the absence of even an indolent, lytic infection. These analyses
confirm at the transcriptional level that the L'l.50 latency system is devoid of contaminating WT
replication, and gives an insight into the latent transcriptional profile.

Total RNA and mRNA were isolated £i·om L'l.50lucgMGFP(BAC-) infected RAW cultures, to
. compare the viral transcript yields between these two sources.Overall, ..similar viral transcript
yields were obtained between the two isolation methods, indicating that the intensive protocol
involved isolating mRNA did not improve transcript yield, and that using total RNA as template
was appropriate (Figure 33).
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Figure 33

RAW macrophages were infected with 10 pfulcell .6.50IucgMGFP(BAC-) viruses pre-incubated
with antigp 150 antibody, and harvested at 1,2,4, and 6 days post infection for RNA. 0.5 J.lgof
RNA was reverse transcribed, and the RT product subjected to Real time PCR against a primer
specific standard curve. The transcript copy numbers for each sample was deducted from minus
RT controls, and normalized to 18S transcript numbers at the corresponding time point. The
transcriptional profile oflatent (M2, ORF73) and lytic (M9, ORF9, ORF50) transcripts are
compared.
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In order to determine the stability of DNA during the latent time course, DNA was isolated from
t.50lucgMGFP(BAC-) and subjected to Real Time PCR (Figure 34). Overall, the DNA of
ORF73, M2 and ORF9 were relatively stable, with a drop in transcript number seen at 2-4 days
in all the viral transcripts tested. This decrease was not due to passaging as for this brief
experiment, cells were not passaged, but were fed fresh 10% DMEM at day 4.
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Figure 34

RAW macrophages were infected with 10 pfu/cell

~50IucgMGFP(BAC-)

virus pre-incubated

with antigpl50 antibody. At 4 d.p.i, media was removed from culture, and replaced with fresh
10% DMEM. Cultures were harvested at 1,2,4, and 6 days post infection. O.5J.lgofDNA was
diluted in 200ul nuclease free water, and SuI aliquots in triplicate subjected to Real time PCR
against a primer specific standard curve. The genome copy number for each sample was
deducted from minus RT controls, and normalized to the genome copy number at the
corresponding time point. The genome copy numbers for latent (M2, ORF73) and lytic(M9,
ORF9, ORF50) genes are compared.
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Having established the transcriptional profile of the Ll50 latency system in comparison to lytic
infection in the permissive 3T3 cell line, and RAW macrophages, a site of latent infection in vivo,
the next step was to determine the transcriptional profile in B cells, the primary site oflatent
infection in vivo.
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Figure 35

NSO cells were infected with a)
~50IucgMGFP(BAC-)

~gp150

at 3 m.oj, b) WT (BAC+) at 7 m.oj, and c)

at 20 m.oj. and harvested at 12, 24 and 72 h.pj, for RNA. 0.5J.lgofRNA

was reverse transcribed, and the RT product subjected to Real time PCR against a primer specific
standard curve. The transcript copy numbers for each sample was deducted from minus RT
controls, and normalized to ISS transcript numbers at the corresponding time point. The
transcriptional profile oflatent (M2, ORF73) and lytic (M9, ORF9, ORF50) transcripts are
compared.
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Over the 72 hour time course, similar total RNA yields were attained at each time point, with
similar 18S rRNA transcript numbers for the three viral cultures. The gp 1SO infected isolates had
the highest of all viral transcripts, consistent with the enhanced infectivity of this mutant in NSO
cells (Figure 35a). Lytic transcripts were characteristically higher than latent transcripts,
although the difference was lower than in RAW or 3T3 cells.

WT viral transcripts bore the same overall relationship to each other as L\.gp I SO viral transcripts,
although there was a lag in infection in WT virus reflecting the non permissive nature of B cells.
ORF9 alone decreased over the 72 hour time course in WT infection, contrary to the 3 log
increase in L'lgp 1SO (Figure 35b).

All viral transcripts were lower at the early 12 hour time point in L'l50lucgMGFP(BAC-) infected
cultures, than either the L'lgp150 (BAC+) or WT (BAC+) infected cultures reflecting the
partiCUlarly poor infectivity ofNSO cells with L'l50lucgMGFP(BAC-). However, a very different
trajectory occurred with L'l50IucgMGFP(BAC-), with all lytic transcripts decreasing within the
first 24 hours, as occurred with L'l50IucgMGFP(BAC-) infection in 3T3cells, but then rising
again from 42 -72 hours, possibly reflecting increasing numbers of cells newly infected by virus
that had previously not entered cells due to poor infectivity (Figure 35c). ORF73 also increases
slightly from 24-72 h.pj while M2 decreases slightly. The low latent transcript yield compared
to lytic transcripts in L'l50lucgMGFP(BAC-) infected NSO cells may reflect a greater efficiency in
latent transcript processing in B cells, such that lower levels of the latent transcripts can achieve
the desired results of episomal maintenance and immune evasion.
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The low proportion of latently infected cells in NSO cultures limits analysis. In order to generate
enriched populations oflatently infected cells, NSO cells infected with Ll.50Iuc(BAC+) were
sorted into GFP positive versus GFP negative populations. The sorting process yields only Ixl 03
GFP positive cells, however B cells proliferate in culture ( Figure 24). At 7 days post sorting, the
number of cells in culture had amplified to approximately I x 10 5 cells/well, and were harvested
at this time point in order to yield adequate amounts of RNA and DNA to assay (Figure 36).
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Figure 36

NSO cells were infected with Li.50lucgMGFP(BAC-) at 20 m.oj, with FACS sorting I day post
infection, into GFP+ and GFP- populations. Cultures were harvested 7 days following sorting,
yielding

a) 0.5flg of RNA which was reverse transcribed, and the RT product diluted in 200fll nuclease
free water, with 8 ul aliquots in triplicate subjected to Real time PCR against a standard curve.

b) 0.5flg of DNA which was diluted in 200fll nuclease free water, and 8fll aliquots in triplicate
subjected to Real time PCR against a primer specific standard curve. The transcript copy
numbers for each sample was deducted from minus RT controls, and normalized to 18S
transcript numbers at the corresponding time point. The transcriptional profile oflatent (M2,
ORF73) and lytic (ORF9) h'anscripts are compared.
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Viral transcripts were expressed at low levels in GFP+ sorted cells, consistent with the latency
objective of immune evasion. No viral transcripts were detected in the infected but unsorted
populations at either I or 7 days, or the GFP negative sorted population, possibly due to the very
low concentration of latently infected cells (Figure 36a). The RNA transcript yield was compared
to DNA yield (Figure 36b). ORF73 DNA was detected in the GFP+ population, but was absent
in the GFP- population, and the infected but unsorted populations. An absence ofORF73
suggests a failure of episomal maintenance, which raises the question whether DNA detected for
the ORF 9 and M2 transcripts is due to extra cellular viral DNA or viral episomal DNA. This
could be clarified with a gardella assay for episomal DNA [Gardella et ai, 1984].

In summary, RT-PCR analysis of fibroblast, macrophage and B cell lines confirm at the
transcriptional level that the ,'1.50 latency system is a tractable latency system which can be
manipulated for the purposes of establishing and maintaining latency, but can also be reactivated
to lytic replication. Furthermore, this work shows that it is a clean latency system devoid of
contaminating WT virus. The immediate challenge is to optimize B cell infection and
maintenance oflatency, with the goal of generating a clonal latent B cell line, which can then be
applied to the search for novel latent transcripts.
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DISCUSSION

The transcriptional profile of Ll.50 MHV -68 virus in latency was characterized and compared to
lytic gene expression, for a representative subset of lytic and latent transcripts. In keeping with
single step growth curves, these studies have confirmed at a transcriptional level that the Ll.50
mutant is fully complemented by ORF50 expressed from the clone 11 cell line, with no
secondary mutations that impact growth (Figure 6 & 30).

The lytic transcriptional profile on infection with WT (BAC+) in permissive 3T3 fibroblasts was
analysed, showing that the lytic transcripts M9 and ORF9 peaked at 24 hpi, the latent transcript
M2 peaked after 24 hpi, and ORF73 stayed within a similar range from 5 h.p.i onwards (Figure
29). This resembles the expression time course seen in previous in vitro studies in BHK-21 cells,
where ORF9 transcript levels peaked at 24 h.p.i, M2 peaked by 32 h.p.i, and ORF73 peaked
within 8 hours [Martinez-Guzman et ai, 2003]. ORF50 transcript levels peaked at 8 h in BHK-21
studies whereas here it peaked at 24 hpi (Figure 29). The reason for a difference in ORF50
expression profiles is unclear.

In RAW macrophages all viral transcripts were still rising at the conclusion. of the 48 hour time
point, while cellular transcripts remained stable. Thus the observation that virus seems to be slow
to enter RAW macrophages, even with gp 150 antibody potentiation, was confinned at the
transcriptional level (Figures 21 & 30).
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While the transcriptional profile during latent infection during the first 14 days oflatency
establishment has been described in vivo, the expression profile during the early phase of latency
establishment with MHV-68 has not previously been described, and in this study was facilitated
by infection of cells with an ORF50 replication defective mutant. In vivo studies of splenic cells
showed by real time PCR the presence of ORF50 at very low levels, but absence ofM2 or
ORF73 in macrophages, while B cells expressed both M2 and ORF73 but no ORF50, at 14 d.p.i
[Marques et at, 2003]. Here, following .6.50lucgMGFP(BAC-) infection of3T3 fibroblasts, M9
transcription peaked at 12 h.p.i, but was undetectable by 60h (Figure 29). ORF9 transcription
peaked by 24 h and was undetectable by 48 hpi. ORF50 transcription peaked by 24 hpi, and in
the absence of the auto activation seen in lytic infection, reached very low levels by 72 hpi. The
amount of ORF50 present never reached zero however, which may be due to residual non
degraded mRNA, or may reflect a constitutive basal level of ORF50 promoter activation.

For the latency transcripts, ORF73 transcription peaked within 5 hours, dropping to very low
levels after 48 hours. M2 transcription peaked by 12 hours, and dropped down to undetectable
levels by 60 h.p.i (Figure 29). Transcripts may appear artificially low between 48 and 72 h.p.i
given that they are normalized against 18S, and 18S expression increased substantially between
48 and 72 hours. On inspection of the non-normalized data, M2 transcript levels were low at 72
h.p.i, however ORF73 transcript levels were at their highest at 72 h.p.i.
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The relationship between transcripts was similar for RAW macrophages to that seen in 3T3
fibroblasts. The major difference was that in RAW macrophages, at 48 h.p.i, all viral transcripts
were still increasing in amounts, following infection with both the WT and "'50IucgMGFP(BAC)viruses( Figure 30); This supports at the transcriptional level, the observation that MHV -68 is
slow to infect RAW macrophages, even in the presence of potentiating antigp150 antibody
(Figure 21).

At the early time points, the relationships between transcripts was complicated, with
transcription levels adjusting to the latent program, with an interplay between viral, cellular and
environmental factors to reach steady state levels. The long term latency experiments over 30
days clarified the relationship between transcripts, with latent and lytic transcripts expressed at
similar levels in both 3T3 fibroblasts and RAW macrophages. Of note, M2 was more highly
expressed in RAW macrophages, than 3T3 fibroblasts, relative to ORF73 (Figures 31 & 32). M2
has anti-apoptotic properties, facilitating differentiation oflatently infected germinal centre B
cells into memory B cells [Simas et aI, 2004]. It also modulates Vav B cell signalling protein
activity, subverting T/CD8+ lymphocytes elimination ofB cells carrying the MHV-68 genome in

vivo. M2 contains a CD8 epitope, thus it is thought that M2 expression results in T cell
recognition and elimination [Rodrigues et aI, 2006]. The higher M2 expression in RAW
macrophages may relate to a higher efficiency in its regulation in macrophages which are
immune cells in which latency naturally occurs.
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The role played by ORF73 in episomal maintenance has been well defined [Ballestas et al,
1999] ; [Fowler et al, 2003]. Importantly, these 30 day assays provided evidence at the
transcriptional level, that the viral genome was being maintained, given the stable levels of
ORF73 in 3T3 fibroblasts and RAW macrophages over the time course ( Figures 31 and 32).
Furthermore, a 6 day time course in RAW cells infected with t.50IucgMGFP(BAC-) showed
DNA to be stable over time (Figure 34). The transcriptional picture reflects the stable
reactivation efficiencies achieved in both cell lines. Furthermore, the 30 day profile proves
conclusively at the transcriptional level, the absence of contaminating lytic virus, with negligible
ORF9 transcription (Figures 18 and 22). The small increase in fluorescence seen in figure 22 is
thus not due to indolent lytic replication, but likely represents a higher level of auto-fluorescence.

The distinct transcriptional profiles seen in latent versus lytic transcription in 3T3 fibroblasts and
RAW macrophages corroborates the GFP expression phenotypes seen in latency experiments
(Chapter 2). On a practical level, this is useful knowledge for the design of future experiments,
where a visual screen oflatently infected cultures can indicate the presence ofWT reversion, in
individual wells, without employing the time consuming assay of real time PCR. Transcriptional
assays also serve as a prelude to sensitive assays for identifYing novel latent transcripts in a
latency system rigorously screened for lytic contamination.
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FUTURE DIRECTIONS

While RAW macrophages do harbour latent MHV -68, B cells are the site oflong tenn latency in
vivo. It will thus be of importance to adequately explore the 1'.50 latency system in a B cell line.
Characterization of the 1'.50 latency system in the NSO B cell line is hampered by inefficient viral
infection. While enriched populations oflatently infected cells can be generated by FACS sorting,
this still produces small numbers of infected cells.

M7 encodes the viral glycoprotein gp ISO. 1'.M7 paradoxically has an enhanced ability to infect
B cells, which express low levels of GAGs, to which gpl50 binds [de Lima et ai, 2004]. In this
study, 1'.M7 was shown to have a reactivation efficiency of 18% following super-infection with
WT virus, compared to 2% reactivation efficiency in cultures latently infected with
1'.50Iuc(BAC+). Construction of a double mutant containing both 1'.M7 and 1'.50 mutations would
be ideal as the enhanced infectivity of 1'.M7 coupled with the latency phenotype of the 1'.50
mutant would allow coordinate latent infection of a significant proportion of B cells. Given the
adjacent locations of these two genes, such a mutant could be made with a deletion spanning that
region. The pathogenesis deficit of the 1'.M7 mutant is decreased virion relea.se from infected
cells, and does not interfere with latency [de Lima et at, 2004]. With a means to co-ordinately
infect large numbers ofB cells in culture, the transcriptional profile in the B cell line could be
explored with the success seen in 3T3 fibroblasts and RAW macrophages. The ideal conclusion
would be to establish a clonal B cell line stably carrying the latent 1'.50 mutant genome.
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With the ability to latently infect and then reactivate the latent !'-50 mutant genome, gene
expression profiles in latent versus lytic infection could be examined. For example, it is now
known that the t-RNA's encoded by MHV-68 each contain an miRNA [Pfeffer et at, 2005]. In
another example, ORF73 is known to produce both a spliced and unsliced transcript [Coleman et
at, 2005]. The expression profiles of these gene products during the establishment and

maintenance oflatency, in comparison to lytic infection, can be examined with in such a system.

Finally, the !'-50 latency system could be applied to the search for novel latent transcripts. A
powerful technique for this purpose is subtractive hybridization, which enables comparison of
two mRNA populations, by obtaining clones of genes expressed in one population but not the
other, in this case latency associated genes, with selective amplification.
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APPENDIX I
Reagents for Latency Experiments
Tissue Culture
Dulbecco's Modified Eagle's Medium (DMEM)
Fetal Calf Serum (FCS)
GMEM -Glasgow Minimum Essential Medium
Doxycycline
Hygromycin
G418
Puromycin

PAA Cell Culture Company
Gibco
PAA Cell Culture Company
Clontech
Clontech
Clontech
Clontech

Carboxymethylcellulose (CMC)
Phosphonoacetic acid (P AA)
Lipopolysaccharide (LPS)

Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich

Flow Cytometry
Bovine Serum Albumin (BSA)

Invitrogen

Luciferase Assay
Gly gly buffer
Sml
l.Sml
2.22ml
91.3ml

O.S M glycylglycine Ph7.8
1M MgS04
180mMEDTA
water

Lysis buffer
2Sml
1ml
12Sfll

gly-gly buffer
2S% Triton-X-100
100mMDTT

Luciferase Assay Buffer
21ml
4.2ml
280fll
280fll

gly-gly buffer
KP04 buffer
100m.MDTT
2S0m.MATP

Luciferin Mix
1ml Luciferin
4ml gly-gly buffer
SOflllM DTT
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APPENDIX II

Reagents Real Time PCR
RNA Aqueous 4 PCR
lOX DNase I Buffer (lOOmM Tris/25mM MgCI/lmM CaCI
2 units/~L DNase I (RNase-free)
I mL 5M Ammonium Acetate -20°C
Water for 64% Ethanol
DNase Inactivation Reagent
Lysis/Binding Solution
(4 M guanidinium isothiocyanate, 100 mM Tris·CI, pH 7.0)
Wash Solution I
Wash Solution 2/3

Ambion

Micro polyA+ Purist
Lysis Solution
(4 M guanidinium isothiocyanate, 100 mM Tris·CI, pH 7.0)
Lysate Wash
Dilution Solution
2X Binding Solution
Wash Solution 112
THE RNA Storage Solution (1 mM Sodium Citrate, pH 6.4)
20 mg Oligo (dT) Cellulose
5 M Ammonium Acetate
Glycogen (5 mg/ml)

Ambion

TurboDNA free Kit
Turbo DNAse (2 Units/ul)
lOX Turbo DNase buffer
DNAase Inactivation Reagent
Nuclease free water

Ambion

Message Sensor RT
lOX RT-PCR Buffer (3mM MgCI at IX)
2,5mM dNTP Mix (2.5 mM each dNTP)
I 0 u/~I RNase Inhibitor
IM-MLVRT
I OuM hGAPDH Control j>rimers
10ng/ul ~I HeLa S3 Control RNA

Ambion
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Real Time PCR
lOX PCR buffer
(ISm.M MgClzrrris.ClI, KCI, (NH4)2S04; p.H 8.7)
MgClz 2SmM
HotStart TAQ Sunits/ul
PCR primers & Taqman Probes
DNA plasmid clones·
d.NTPS IOuM

162

Qiagen

TIB MolBio! Berlin
Dr Heather Coleman
Roche

APPENDIX III: REAL TIME PCR DATA SETS FOR 3T3 FIBROBLASTS AND RAW ·
MACROPHAGE INFECTIONS with ~50lucgMGFP(BAC-) OVER 30 DAYS

FIGURE 31: 18S PRIMER SET
Sample

1

5

10

15

20

25

Repeats

Ct value

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1

6.49
6.75
7.29
5.46
5.77
6.59
6.65
6.9
6.59
5.33
5.52
5.65
6.03
5.86
5.66
5.31
5.28
4.74
7.71
7.52
13.58

2
30

3
1
2
3

Copy
No,per
reaction

Std Dev of Ct
values

Mean of Ct
Values

no template
control

6.84

0.41

345,271,432

2,251

5.7

0.07

622,039,700

1,859

6.71

0.17

369,042,736

1,709

5.67

0.24

629,221 ,600

1,547

6.03

0.32

525,087,682

1,868

5.11

3.44

840,694,379

1,661

9.6

0.04

83,935,291

2,354
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Figgre 31: ORF 9 PRIMER SET
Sample

1

5

10

15

20

25

30

Repeats

Ct value

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

25.22
80
25.23
24.32
24.28
24.19
24.75
24.73
24.67
25.84
25.73
25.58
33.83
34.55
35.65
33.07
33.57
33.56
38.13
35.8
36.23

Mean of Ct
Values

Copy
No,per
reaction

Std Dev of Ct
values

no template
control

25.24

0.03

1

0

24.26

0.07

3

0

24.72

0.04

2

0

25.7

4.95

0

0

0

0

34.6

33.4

0.29

0

0

36.72

1.24

0

0
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FIGURE 31: M2 PRIMER SET

sample

1

5

10

15

20

25

30

Repeats

Ct value

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

29.47
29.35
29.57
29.73
29.67
29.87
30.9
30.76
31.03
31.8
31.85
31.83
31.5
31.46
31.7
27.99
27.94
28.1
32.67
32.29
32.47

Mean of Ct
Values

Copy
No,per
reaction

Std Dev of Ct
values

no template
control

29.39

0.07

1167

0

29.73

0.12

921

4

30.9

0.14

412

1

31.69

0.17

239

1

31.5

0

273

1

28.01

0.08

3020

0

32.46

0

140

0

165
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FIGURE 32: M2 PRIMER SET

repeats

sample
1

5

10

15

20

1
2
3
1
2
3
1
2
3
1
2
3
1

2
25

3
1

2
30

3
1
2
3

Ct value
22.68
22-Jan
22.53
20.69
20.72
20.71
21.39
21.49
21.11
22.68
22.67
22.69
23.79
23.82
23.57
21.89
21.96
21.82
25.81
25.82
25.83

0.08

Copy
No,per
reaction
7319

19.99

0.02

26093

1

19.55

0.2

17160

0

20.26

0.01

6965

2

23.05

0.14

3444

2

19.58

0.007

11781

25.9

0.02

846

Mean of Ct
Values
21.37

Std Dev of Ct
values
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no template
controls
0

0

FIGURE 32: ORF73 PRIMER SET

sample

repeats

1

5

10

15

Ct value

1
2
3
1
2
3
1
2
3
1
2
3

20

25

30

2
3
1
2
3
1
2
3

21.37·
21.33
21.42
19.83
20.11
20.02
19.55
19.64
19.46
20.26
20.34
20.18
23.08
23.1
22.98
19.47
19.58
19.68
25.83
26.06
25.8

Mean of Ct
Values

Copy
No,per
reaction

Std Dev of Ct
values

no template
control

21.37

0.04

278

0

19.99

0.14

729

0

19.55

0.09

989

0

20.26

0.08

600

0

23.05

0.07

85

0

19.58

0.11

971

0

25.9

0.14

11

0
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FIGURE 32: ORF9 PRMER SET

sample

repeats
1

5

10

15

20

25

30

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

Ct value
31.76
32.06
35.72
28.08
27.97
32.01
31 .98
32.22
28.07
33.59
32.54
31.89
34.89
34.72
34.97
30.13
30.66
32.91
33.95
33.26
34.77

Mean of Ct
Values
32.14

Copy
No.per
reaction

Std Dev of Ct
values

Control

0.46

2

0

28.04

0.06

36

0

32.03

0.17

2

0

33.7

1.22

0

0

34.17

1.1

0

0

30.45

0.18

6

0

33.98

0.28

0

0
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FIGURE 32: 18S PRIMER SET

sample

repeats

1

5

10

15

20

25

30

Ct value

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

20.7
20.73
20 .83
19.17
19.59
19.19
20.71
20.68
20.72
21.71
20.68
20
12
12.38
12.2
12.86
12.73
12.03
12.28
12.69
12.23

Mean of Ct
Values

Copy
No,per
reaction

Std Dev of Ct
values

no template
control

20.47

0.05

37,845,419

35,459

19.29

0.26

99,844,656

1,11 6
1,116

20.07

0.02

39,920,883

842

21.6

0.17

22,231,380

98

12.19

0.19

1,845
1.0095E+l0

12.54

0.45

12.39

8042930053

0

8866986505

0

0.26
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